UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | R | S | T | U | V | W | Y | Z
Number of items: 388.


Abramov, AY; Duchen, MR; (2010) Impaired mitochondrial bioenergetics determines glutamate-induced delayed calcium deregulation in neurons. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS , 1800 (3) 297 - 304. 10.1016/j.bbagen.2009.08.002.

Abramov, AY; Smulders-Srinivasan, TK; Kirby, DM; Acin-Perez, R; Enriquez, JA; Lightowlers, RN; Duchen, MR; (2010) Mechanism of neurodegeneration of neurons with mitochondrial DNA mutations. BRAIN , 133 797 - 807. 10.1093/brain/awq015.

Abramsson, A; Westman-Brinkmalm, A; Pannee, J; Gustavsson, M; von Otter, M; Blennow, K; Brinkmalm, G; (2010) Proteomics profiling of single organs from individual adult zebrafish. Zebrafish , 7 (2) pp. 161-168. 10.1089/zeb.2009.0644.

Aggarwal, A; Schneider, SA; Houlden, H; Silverdale, M; Paudel, R; Paisan-Ruiz, C; Desai, S; (2010) Indian-Subcontinent NBIA: Unusual Phenotypes, Novel PANK2 Mutations, and Undetermined Genetic Forms. MOVEMENT DISORD , 25 (10) 1424 - 1431. 10.1002/mds.23095.

Aguirregomozcorta, M; Edwards, MJ; Prvulovich, E; Schneider, SA; Quinn, NP; Lees, AJ; Dickson, JC; (2010) Why do clinicians request DaT scans? An analysis of requesting practice and outcome in 455 consecutive scans. In: MOVEMENT DISORDERS. (pp. S369 - S369).

Ahluwalia, J; Tinker, A; Clapp, LH; Duchen, MR; Abramov, AY; Pope, S; Nobles, M; (2010) The large-conductance Ca2+-activated K+ channel is essential for innate immunity (Retraction of vol 427, pg 853, 2004). NATURE , 468 (7320) 122 - 122. 10.1038/nature09562.

Ahmed, M; Miller, AD; Hanna, MG; Greensmith, L; (2010) Heat shock protein induction as a therapeutic strategy for inclusion body myositis. In: NEUROMUSCULAR DISORDERS. (pp. S27 - S27). PERGAMON-ELSEVIER SCIENCE LTD

Ahmed, Z; Asi, YT; Lees, AJ; Revesz, T; Holton, JL; (2010) Oligodendrocyte precursor cells do not contain pathological inclusions in multiple system atrophy or progressive supranuclear palsy. In: BRAIN PATHOLOGY. (pp. 28 - 29). WILEY-BLACKWELL PUBLISHING, INC

Ahmed, Z; Tabrizi, S; Li, A; Houlden, H; Sailer, A; Lees, AJ; Revesz, T; (2010) A case of Huntington's disease phenocopy characterised by pallido-nigro-luysian degeneration with brain-iron accumulation and p62-positive glial inclusions. In: EUROPEAN JOURNAL OF NEUROLOGY. (pp. 379 - 379). WILEY-BLACKWELL

Ahmed, Z; Tabrizi, SJ; Li, A; Houlden, H; Sailer, A; Lees, AJ; Revesz, T; (2010) A Huntington's disease phenocopy characterized by pallido-nigro-luysian degeneration with brain iron accumulation and p62-positive glial inclusions. NEUROPATH APPL NEURO , 36 (6) 551 - 557. 10.1111/j.1365-2990.2010.01093.x.

Ali, N; Woodward, CE; Sweeney, M; Phadke, R; Holton, JL; Acheson, J; Plant, GT; (2010) Pupillary Dysfunction in an Atypical Case of Mitochondrial Myopathy With Tubular Aggregates. JOURNAL OF NEURO-OPHTHALMOLOGY , 30 (2) pp. 153-156. 10.1097/WNO.0b013e3181dbfdcd.

Alonso-Canovas, A; Katschnig, P; Tucci, A; Carecchio, M; Wood, NW; Edwards, M; Castrillo, JCM; (2010) Atypical Parkinsonism with Apraxia and Supranuclear Gaze Abnormalities in Type 1 Gaucher Disease. Expanding the Spectrum: Case Report and Literature Review. MOVEMENT DISORD , 25 (10) 1506 - 1509. 10.1002/mds.23109.

Alves, G; Brønnick, K; Aarsland, D; Blennow, K; Zetterberg, H; Ballard, C; Kurz, MW; (2010) CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry , 81 (10) pp. 1080-1086. 10.1136/jnnp.2009.199950.

Anaya, FJ; Vandrovcova, J; Lees, A; de Silva, R; (2010) Investigation of the role of tau gene transcriptional regulation in neurodegeneration. In: MOVEMENT DISORDERS. (pp. S200 - S201). WILEY-LISS

Anderson, JM; Patani, R; Reynolds, R; Nicholas, R; Compston, A; Spillantini, MG; Chandran, S; (2010) Abnormal tau phosphorylation in primary progressive multiple sclerosis. Acta Neuropathol , 119 (5) pp. 591-600. 10.1007/s00401-010-0671-4.

Andreasen, N; Blennow, K; Zetterberg, H; (2010) Neuroinflammation Screening in Immunotherapy Trials against Alzheimer's Disease. Int J Alzheimers Dis , 2010 638379-. 10.4061/2010/638379.

Annaert, W; De Strooper, B; (2010) Alzheimer's disease neurons fail the acid test. Cell , 141 (7) pp. 1112-1114. 10.1016/j.cell.2010.06.009.

Antonarakis, SE; Chakravarti, A; Cohen, JC; Hardy, J; (2010) Mendelian disorders and multifactorial traits: the big divide or one for all? NAT REV GENET , 11 (5) 380 - 384. 10.1038/nrg2793.


Bajaj, NP; Gontu, V; Birchall, J; Patterson, J; Grosset, DG; Lees, AJ; (2010) Accuracy of clinical diagnosis in tremulous parkinsonian patients: a blinded video study. J Neurol Neurosurg Psychiatry , 81 (11) pp. 1223-1228. 10.1136/jnnp.2009.193391.

Balldin, J; Berggren, U; Berglund, K; Blennow, K; Fahlke, C; Zetterberg, H; (2010) Gamma-glutamyltransferase in alcohol use disorders: Modification of decision limits in relation to treatment goals? Scand J Clin Lab Invest , 70 (2) pp. 71-74. 10.3109/00365510903406694.

Bandopadhyay, R; Phan, B; Mamais, A; Lashley, T; Lees, A; (2010) Validation of 4E-BP1 as a Putative LRRK2 Substrate: In Vivo Evidence. In: MOVEMENT DISORD. (pp. S629 - S629). WILEY-LISS

Bandopadhyay, R; de Belleroche, J; (2010) Pathogenesis of Parkinson's disease: emerging role of molecular chaperones. TRENDS MOL MED , 16 (1) 27 - 36. 10.1016/j.molmed.2009.11.004.

Bayot, A; Gareil, M; Rogowska-Wrzesinska, A; Roepstorff, P; Friguet, B; Bulteau, AL; (2010) Identification of novel oxidized protein substrates and physiological partners of the mitochondrial ATP-dependent Lon-like protease Pim1. J Biol Chem , 285 (15) pp. 11445-11457. 10.1074/jbc.M109.065425.

Beck, JA; Poulter, M; Campbell, TA; Adamson, G; Uphill, JB; Guerreiro, R; Jackson, GS; (2010) PRNP Allelic Series From 19 Years of Prion Protein Gene Sequencing at the MRC Prion Unit. HUM MUTAT , 31 (7) E1551 - E1563. 10.1002/humu.21281.

Benilova, I; De Strooper, B; (2010) Prion protein in Alzheimer's pathogenesis: a hot and controversial issue. EMBO Mol Med , 2 (8) pp. 289-290. 10.1002/emmm.201000088.

Berggren, U; Fahlke, C; Berglund, KJ; Wadell, K; Zetterberg, H; Blennow, K; Thelle, D; (2010) Dopamine D2 receptor genotype is associated with increased mortality at a 10-year follow-up of alcohol-dependent individuals. Alcohol Alcohol , 45 (1) pp. 1-5. 10.1093/alcalc/agp041.

Bergmans, BA; De Strooper, B; (2010) gamma-secretases: from cell biology to therapeutic strategies. Lancet Neurol , 9 (2) pp. 215-226. 10.1016/S1474-4422(09)70332-1.

Bergmans, BA; Shariati, SA; Habets, RL; Verstreken, P; Schoonjans, L; Müller, U; Dotti, CG; (2010) Neurons generated from APP/APLP1/APLP2 triple knockout embryonic stem cells behave normally in vitro and in vivo: lack of evidence for a cell autonomous role of the amyloid precursor protein in neuronal differentiation. Stem Cells , 28 (3) pp. 399-406. 10.1002/stem.296.


Bishop, MW; Chakraborty, S; Matthews, GAC; Dougalis, A; Wood, NW; Festenstein, R; Ungless, MA; (2010) Hyperexcitable Substantia Nigra Dopamine Neurons in PINK1- and HtrA2/Omi-Deficient Mice. J NEUROPHYSIOL , 104 (6) 3009 - 3020. 10.1152/jn.00466.2010.

Bjerke, M; Portelius, E; Minthon, L; Wallin, A; Anckarsäter, H; Anckarsäter, R; Andreasen, N; (2010) Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid. Int J Alzheimers Dis , 2010 10.4061/2010/986310.

Blennow, K; Hampel, H; Weiner, M; Zetterberg, H; (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol , 6 (3) pp. 131-144. 10.1038/nrneurol.2010.4.

Blennow, K; Zetterberg, H; (2010) Is it time for biomarker-based diagnostic criteria for prodromal Alzheimer's disease? Alzheimers Res Ther , 2 (2) 8-. 10.1186/alzrt31.

Bogas, M; Machado, P; Mourão, AF; Costa, L; Santos, MJ; Fonseca, JE; Silva, JA; (2010) Methotrexate treatment in rheumatoid arthritis: management in clinical remission, common infection and tuberculosis. Results from a systematic literature review. Clin Rheumatol , 29 (6) pp. 629-635. 10.1007/s10067-010-1380-z.

Bossolasco, P; Cova, L; Calzarossa, C; Servida, F; Mencacci, NE; Onida, F; Polli, E; (2010) Metalloproteinase alterations in the bone marrow of ALS patients. Journal of Molecular Medicine , 88 (6) pp. 553-564. 10.1007/s00109-009-0584-7.

Bromander, S; Anckarsäter, R; Ahrén, B; Kristiansson, M; Blennow, K; Holmäng, A; Zetterberg, H; (2010) Cerebrospinal fluid insulin during non-neurological surgery. J Neural Transm (Vienna) , 117 (10) pp. 1167-1170. 10.1007/s00702-010-0456-x.

Brunnström, H; Rawshani, N; Zetterberg, H; Blennow, K; Minthon, L; Passant, U; Englund, E; (2010) Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses. Alzheimers Dement , 6 (2) pp. 104-109. 10.1016/j.jalz.2009.12.005.

Buchhave, P; Zetterberg, H; Blennow, K; Minthon, L; Janciauskiene, S; Hansson, O; (2010) Soluble TNF receptors are associated with Aβ metabolism and conversion to dementia in subjects with mild cognitive impairment. Neurobiol Aging , 31 (11) pp. 1877-1884. 10.1016/j.neurobiolaging.2008.10.012.

Burchell, VS; Gandhi, S; Deas, E; Wood, NW; Abramov, AY; Plun-Favreau, H; (2010) Targeting mitochondrial dysfunction in neurodegenerative disease: Part I. EXPERT OPIN THER TAR , 14 (4) 369 - 385. 10.1517/14728221003652489.

Burchell, VS; Gandhi, S; Deas, E; Wood, NW; Abramov, AY; Plun-Favreau, H; (2010) Targeting mitochondrial dysfunction in neurodegenerative disease: Part II. EXPERT OPIN THER TAR , 14 (5) 497 - 511. 10.1517/14728221003730434.


Chalbot, S; Zetterberg, H; Blennow, K; Fladby, T; Grundke-Iqbal, I; Iqbal, K; (2010) Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity: a biomarker of blood-cerebrospinal fluid barrier permeability. Neurosci Lett , 478 (3) pp. 179-183. 10.1016/j.neulet.2010.05.012.

Chiasserini, D; Parnetti, L; Andreasson, U; Zetterberg, H; Giannandrea, D; Calabresi, P; Blennow, K; (2010) CSF levels of heart fatty acid binding protein are altered during early phases of Alzheimer's disease. J Alzheimers Dis , 22 (4) pp. 1281-1288. 10.3233/JAD-2010-101293.

Clark, RH; McTaggart, JS; Webster, R; Mannikko, R; Iberl, M; Sim, XL; Rorsman, P; (2010) Muscle dysfunction caused by a KATP channel mutation in neonatal diabetes is neuronal in origin. Science , 329 (5990) pp. 458-461. 10.1126/science.1186146.

Compta, Y; Parkkinen, L; Vandrovcova, J; O'Sullivan, S; Holton, J; de Silva, R; Lashley, T; (2010) Lewy-and Alzheimer-type pathologies in Parkinson's disease with dementia: A comprehensive brain-bank study. In: MOVEMENT DISORDERS. (pp. S317 - S317). WILEY-LISS

Constantinescu, R; Andreasson, U; Li, S; Podust, VN; Mattsson, N; Anckarsäter, R; Anckarsäter, H; (2010) Proteomic profiling of cerebrospinal fluid in parkinsonian disorders. Parkinsonism Relat Disord , 16 (8) pp. 545-549. 10.1016/j.parkreldis.2010.06.011.

Constantinescu, R; Rosengren, L; Johnels, B; Zetterberg, H; Holmberg, B; (2010) Consecutive analyses of cerebrospinal fluid axonal and glial markers in Parkinson's disease and atypical Parkinsonian disorders. Parkinsonism Relat Disord , 16 (2) pp. 142-145. 10.1016/j.parkreldis.2009.07.007.

Corneveaux, JJ; Myers, AJ; Allen, AN; Pruzin, JJ; Ramirez, M; Engel, A; Nalls, MA; (2010) Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. Human Molecular Genetics , 19 (16) pp. 3295-3301. 10.1093/hmg/ddq221.

Corneveaux, JJ; Myers, AJ; Allen, AN; Pruzin, JJ; Ramirez, M; Engel, A; Nalls, MA; (2010) Association of CR1, CLU and PICALM with Alzheimer's disease in a cohort of clinically characterized and neuropathologically verified individuals. HUM MOL GENET , 19 (16) 3295 - 3301. 10.1093/hmg/ddq221.

Corvelo, A; Hallegger, M; Smith, CW; Eyras, E; (2010) Genome-wide association between branch point properties and alternative splicing. PLoS Comput Biol , 6 (11) , Article e1001016. 10.1371/journal.pcbi.1001016.

Crowther-Swanepoel, D; Broderick, P; Ma, Y; Robertson, L; Pittman, AM; Price, A; Twiss, P; (2010) Fine-scale mapping of the 6p25.3 chronic lymphocytic leukaemia susceptibility locus. Hum Mol Genet , 19 (9) pp. 1840-1845. 10.1093/hmg/ddq044.


Daborg, J; von Otter, M; Sjölander, A; Nilsson, S; Minthon, L; Gustafson, DR; Skoog, I; (2010) Association of the RAGE G82S polymorphism with Alzheimer's disease. J Neural Transm (Vienna) , 117 (7) pp. 861-867. 10.1007/s00702-010-0437-0.

Dale, RC; Melchers, A; Fung, VSC; Grattan-Smith, P; Houlden, H; Earl, J; (2010) Familial paroxysmal exercise-induced dystonia: atypical presentation of autosomal dominant GTP-cyclohydrolase 1 deficiency. DEV MED CHILD NEUROL , 52 (6) 583 - 586. 10.1111/j.1469-8749.2010.03619.x.

Davendralingam, N; Davagnanam, I; Djamshidian, A; Lees, A; (2010) Picture Quiz Progressive dysphagia, dysarthria, dystonia, and tremor. BRIT MED J , 340 , Article c1213. 10.1136/bmj.c1213.

Davenport, CM; Sevastou, IG; Hooper, C; Pocock, JM; (2010) Inhibiting p53 pathways in microglia attenuates microglial-evoked neurotoxicity following exposure to Alzheimer peptides. J NEUROCHEM , 112 (2) 552 - 563. 10.1111/j.1471-4159.2009.06485.x.

Davidson, G; Murphy, SM; Polke, JM; Davis, MB; Reilly, M; Houlden, H; MRC Ctr Neuromuscular Dis, ; (2010) Genes for hereditary sensory and autonomic neuropathies: frequency in a UK series and genotype-phenotype correlations. In: NEUROMUSCULAR DISORDERS. (pp. S22 - S22). PERGAMON-ELSEVIER SCIENCE LTD

De Meyer, G; Shapiro, F; Vanderstichele, H; Vanmechelen, E; Engelborghs, S; De Deyn, PP; Coart, E; (2010) Diagnosis-independent Alzheimer disease biomarker signature in cognitively normal elderly people. Arch Neurol , 67 (8) pp. 949-956. 10.1001/archneurol.2010.179.

De Strooper, B; (2010) Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process. Physiol Rev , 90 (2) pp. 465-494. 10.1152/physrev.00023.2009.

De Strooper, B; (2010) The molecular study of Alzheimer's disease: The road to a causal treatment. Tijdschrift voor Geneeskunde , 66 (23) pp. 1150-1155. 10.2143/TVG.66.23.2000874.

De Strooper, B; Annaert, W; (2010) Novel research horizons for presenilins and γ-secretases in cell biology and disease. Annu Rev Cell Dev Biol , 26 pp. 235-260. 10.1146/annurev-cellbio-100109-104117.

De Strooper, B; Vassar, R; Golde, T; (2010) The secretases: enzymes with therapeutic potential in Alzheimer disease. Nat Rev Neurol , 6 (2) pp. 99-107. 10.1038/nrneurol.2009.218.

Dewar, L; Matthews, E; Bahlke, G; Hanna, MG; (2010) Quantification of grip myotonia using a novel accelerometer device: a pilot study. In: NEUROMUSCULAR DISORDERS. (pp. S17 - S17). PERGAMON-ELSEVIER SCIENCE LTD

Dick, KJ; Eckhardt, M; Paisan-Ruiz, C; Alshehhi, AA; Proukakis, C; Sibtain, NA; Maier, H; (2010) Mutation of FA2H Underlies a Complicated Form of Hereditary Spastic Paraplegia (SPG35). HUM MUTAT , 31 (4) E1251 - E1260. 10.1002/humu.21205.

Djamshidian, A; Jha, A; O'Sullivan, S; Silvera-Moriyama, L; Jacobsen, C; Brown, P; Lees, A; (2010) Risk and learning in impulsive and non-impulsive patients with Parkinson's disease. In: MOVEMENT DISORDERS. (pp. S279 - S279). WILEY-LISS

Djamshidian, A; Jha, A; O'Sullivan, SS; Silveira-Moriyama, L; Jacobson, C; Brown, P; Lees, A; (2010) Risk and Learning in Impulsive and Nonimpulsive Patients With Parkinson's Disease. MOVEMENT DISORD , 25 (13) 2203 - 2210. 10.1002/mds.23247.

Djamshidian, A; Jha, A; O'Sullivan, SS; Silveira-Moriyama, L; Jacobson, C; Brown, P; Lees, A; (2010) Risk and learning in impulsive and nonimpulsive patients with Parkinson's disease. Movement Disorders , 25 (13) pp. 2203-2210. 10.1002/mds.23247.

Doherty, K; Silveira-Moriyama, L; Ahmed, Z; Revesz, T; Holton, J; Lees, A; (2010) A Clinicopathological Study of a Case of Parkinson's Disease. In: MOVEMENT DISORD. (pp. S640 - S641). WILEY-LISS

Doherty, KM; Ahmed, Z; Silveira-Moriyama, L; O'Sullivan, SS; Wroe, S; Holton, JL; Lees, AJ; (2010) Progressive supranuclear palsy (PSP) with prominent corticospinal tract degeneration in motor neuron disease (MND). In: MOVEMENT DISORDERS. (pp. S497 - S497). WILEY-LISS

Doherty, KMC; Ahmed, Z; Revesz, T; Holton, JL; Lees, AJ; (2010) A clinicopathological study of a case of parkin disease. In: MOVEMENT DISORDERS. (pp. S471 - S471). WILEY-LISS


Dressler, D; Warner, T; (2010) Dystonia Europe: Hamburg 2008. European Journal of Neurology , 17 (SUPPL. 1) 10.1111/j.1468-1331.2010.03062.x.

Dressler, D; Warner, T; (2010) Dystonia Europe: Hamburg 2008. Foreword. Eur J Neurol , 17 Sup v-. 10.1111/j.1468-1331.2010.03062.x.

Duff, K; Paulsen, J; Mills, J; Beglinger, LJ; Moser, DJ; Smith, MM; Langbehn, D; (2010) Mild cognitive impairment in prediagnosed Huntington disease. Neurology , 75 (6) pp. 500-507. 10.1212/WNL.0b013e3181eccfa2.

de Strooper, B; (2010) Cancer and neurodegeneration meet. EMBO Mol Med , 2 (7) pp. 245-246. 10.1002/emmm.201000078.


Eckerström, C; Andreasson, U; Olsson, E; Rolstad, S; Blennow, K; Zetterberg, H; Malmgren, H; (2010) Combination of hippocampal volume and cerebrospinal fluid biomarkers improves predictive value in mild cognitive impairment. Dement Geriatr Cogn Disord , 29 (4) pp. 294-300. 10.1159/000289814.

Eerola, J; Luoma, PT; Peuralinna, T; Scholz, S; Paisan-Ruiz, C; Suomalainen, A; Singleton, AB; (2010) POLG1 polyglutamine tract variants associated with Parkinson's disease. NEUROSCI LETT , 477 (1) 1 - 5. 10.1016/j.neulet.2010.04.021.

Eggert, K; Squillacote, D; Barone, P; Dodel, R; Katzenschlager, R; Emre, M; Lees, AJ; (2010) Safety and efficacy of perampanel in advanced Parkinson's disease: a randomized, placebo-controlled study. Mov Disord , 25 (7) pp. 896-905. 10.1002/mds.22974.

Espuny-Camacho, I; Dominguez, D; Merchiers, P; Van Rompaey, L; Selkoe, D; De Strooper, B; (2010) Peroxisome proliferator-activated receptor gamma enhances the activity of an insulin degrading enzyme-like metalloprotease for amyloid-beta clearance. J Alzheimers Dis , 20 (4) pp. 1119-1132. 10.3233/JAD-2010-091633.

Evans, AH; Lawrence, AD; Cresswell, SA; Katzenschlager, R; Lees, AJ; (2010) Compulsive use of dopaminergic drug therapy in Parkinson's disease: reward and anti-reward. Mov Disord , 25 (7) pp. 867-876. 10.1002/mds.22898.


Faux, NG; Ritchie, CW; Gunn, A; Rembach, A; Tsatsanis, A; Bedo, J; Harrison, J; (2010) PBT2 rapidly improves cognition in Alzheimer's Disease: additional phase II analyses. J Alzheimers Dis , 20 (2) pp. 509-516. 10.3233/JAD-2010-1390.

Ferrari, R; Kapogiannis, D; Huey, ED; Grafman, J; Hardy, J; Momeni, P; (2010) Novel Missense Mutation in Charged Multivesicular Body Protein 2B in a Patient With Frontotemporal Dementia. ALZ DIS ASSOC DIS , 24 (4) 397 - 401. 10.1097/WAD.0b013e3181df20c7.

Finegold, J; Giunti, P; Mckenna, W; Elliott, P; Pantazis, A; (2010) Description of the cardiomyopathy associated with friedreich's ataxia. In: EUROPEAN HEART JOURNAL. (pp. 37 - 37). OXFORD UNIV PRESS

Fleming, SM; Weil, RS; Nagy, Z; Dolan, RJ; Rees, G; (2010) Relating Introspective Accuracy to Individual Differences in Brain Structure. SCIENCE , 329 (5998) 1541 - 1543. 10.1126/science.1191883.

Fonseca, JE; Canhão, H; Reis, P; Santos, MJ; Branco, J; Quintal, A; Malcata, A; (2010) Portuguese guidelines for the use of biological agents in rheumatoid arthritis - March 2010 update. Acta Reumatol Port , 35 (1) pp. 95-98.

Fonteyn, EMR; Schmitz-Hubsch, T; Verstappen, CC; Baliko, L; Bloem, BR; Boesch, S; Bunn, L; (2010) Falls in Spinocerebellar Ataxias: Results of the EuroSCA Fall Study. CEREBELLUM , 9 (2) 232 - 239. 10.1007/s12311-010-0155-z.

Fratter, C; Gorman, GS; Stewart, JD; Buddles, M; Smith, C; Evans, J; Seller, A; (2010) The clinical, histochemical, and molecular spectrum of PEO1 (Twinkle)-linked adPEO. NEUROLOGY , 74 (20) 1619 - 1626.

Fratter, C; Gorman, GS; Stewart, JD; Buddles, M; Smith, C; Evans, J; Seller, A; (2010) The clinical, histochemical, and molecular spectrum of PEO1 (Twinkle)-linked adPEO. NEUROLOGY , 74 (20) pp. 1619-1626.


Gallagher, D; Lees, A; Schrag, A; (2010) Clinical characteristics of patients with visual hallucinations (VH) in PD. In: MOVEMENT DISORDERS. (pp. S279 - S280).

Gallagher, D; Lees, A; Schrag, A; (2010) Testing an aetiological model of visual hallucinations in Parkinson's disease. In: MOVEMENT DISORDERS. (pp. S280 - S280).

Gallagher, D; Spratt, A; Shah, A; Bremmer, F; Davey, C; Lees, A; Schrag, A; (2010) Ophthalmic pathology and visual hallucinations (VH) in PD. In: MOVEMENT DISORDERS. (pp. S280 - S280).

Gallagher, DA; Lees, AJ; Schrag, A; (2010) What Are the Most Important Nonmotor Symptoms in Patients with Parkinson's Disease and Are We Missing Them? MOVEMENT DISORD , 25 (15) 2493 - 2500. 10.1002/mds.23394.

Gallagher, DA; Lees, AJ; Schrag, A; (2010) What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them? Movement Disorders , 25 (15) pp. 2493-2500. 10.1002/mds.23394.

Gandhi, S; Wood, NW; (2010) Genome-wide association studies: the key to unlocking neurodegeneration? NAT NEUROSCI , 13 (7) 789 - 794. 10.1038/nn.2584.

Gao, CM; Yam, AY; Wang, X; Magdangal, E; Salisbury, C; Peretz, D; Zuckermann, RN; (2010) Aβ40 oligomers identified as a potential biomarker for the diagnosis of Alzheimer's disease. PLoS One , 5 (12) , Article e15725. 10.1371/journal.pone.0015725. Green open access

Garcia, IL; Darquie, B; Curtis, EA; Sinclair, CDJ; Hinds, EA; (2010) Experiments on a videotape atom chip: fragmentation and transport studies. NEW J PHYS , 12 , Article 093017. 10.1088/1367-2630/12/9/093017. Gold open access

Garcia-Reitböck, P; Anichtchik, O; Bellucci, A; Iovino, M; Ballini, C; Fineberg, E; Ghetti, B; (2010) SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease. Brain , 133 (Pt 7) pp. 2032-2044. 10.1093/brain/awq132.

Gastaldello, A; Callaghan, H; Gami, P; Campanella, M; (2010) Ca 2+ -dependent autophagy is enhanced by the pharmacological agent PK11195. Autophagy , 6 (5) pp. 607-613. 10.4161/auto.6.5.11964.

Granata, A; Warner, TT; (2010) The role of torsinA in dystonia. In: EUROPEAN JOURNAL OF NEUROLOGY. (pp. 81 - 87). WILEY-BLACKWELL PUBLISHING, INC

Granata A, WTT; (2010) The role of TorsinA in dystonia. Eur J Neurol , 17 (Suppl.) pp. 81-87.


Graves, TD; Rajakulendran, S; Zuberi, SM; Morris, HR; Schorge, S; Hanna, MG; Kullmann, DM; (2010) Nongenetic factors influence severity of episodic ataxia type 1 in monozygotic twins. NEUROLOGY , 75 (4) 367 - 372. 10.1212/WNL.0b013e3181ea9ee3.

Green, P; Wiseman, M; Crow, YJ; Houlden, H; Riphagen, S; Lin, JP; Raymond, FL; (2010) Brown-Vialetto-Van Laere Syndrome, a Ponto-Bulbar Palsy with Deafness, Is Caused by Mutations in C20orf54. AM J HUM GENET , 86 (3) 485 - 489. 10.1016/j.ajhg.2010.02.006.

Gudmundsson, P; Skoog, I; Waern, M; Blennow, K; Zetterberg, H; Rosengren, L; Gustafson, D; (2010) Is there a CSF biomarker profile related to depression in elderly women? Psychiatry Res , 176 (2-3) pp. 174-178. 10.1016/j.psychres.2008.11.012.

Guerreiro, RJ; Baquero, M; Blesa, R; Boada, M; Bras, JM; Bullido, MJ; Calado, A; (2010) Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP. NEUROBIOL AGING , 31 (5) 725 - 731. 10.1016/j.neurobiolaging.2008.06.012.

Guerreiro, RJ; Beck, J; Gibbs, JR; Santana, I; Rossor, MN; Schott, JM; Nalls, MA; (2010) Genetic Variability in CLU and Its Association with Alzheimer's Disease. PLOS ONE , 5 (3) , Article e9510. 10.1371/journal.pone.0009510. Green open access

Guerreiro, RJ; Washecka, N; Hardy, J; Singleton, A; (2010) A Thorough Assessment of Benign Genetic Variability in GRN and MAPT. HUM MUTAT , 31 (2) E1126 - E1140. 10.1002/humu.21152.


Hallegger, M; Llorian, M; Smith, CW; (2010) Alternative splicing: global insights. FEBS J , 277 (4) pp. 856-866. 10.1111/j.1742-4658.2009.07521.x.

Hallegger, M; Sobala, A; Smith, CW; (2010) Four exons of the serotonin receptor 4 gene are associated with multiple distant branch points. RNA , 16 (4) pp. 839-851. 10.1261/rna.2013110.

Hampel, H; Blennow, K; Shaw, LM; Hoessler, YC; Zetterberg, H; Trojanowski, JQ; (2010) Total and phosphorylated tau protein as biological markers of Alzheimer's disease. Exp Gerontol , 45 (1) pp. 30-40. 10.1016/j.exger.2009.10.010.

Hampel, H; Frank, R; Broich, K; Teipel, SJ; Katz, RG; Hardy, J; Herholz, K; (2010) Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives. NATURE REVIEWS DRUG DISCOVERY , 9 (7) pp. 560-574. 10.1038/nrd3115.

Hampel, H; Shen, Y; Walsh, DM; Aisen, P; Shaw, LM; Zetterberg, H; Trojanowski, JQ; (2010) Biological markers of amyloid beta-related mechanisms in Alzheimer's disease. Exp Neurol , 223 (2) pp. 334-346. 10.1016/j.expneurol.2009.09.024.

Hanger, DP; Wray, S; (2010) Tau cleavage and tau aggregation in neurodegenerative disease. BIOCHEMICAL SOCIETY TRANSACTIONS , 38 pp. 1016-1020. 10.1042/BST0381016.

Hansson, O; Zetterberg, H; Blennow, K; (2010) Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment. Neurobiology of Aging , 31 (4) 541-. 10.1016/j.neurobiolaging.2008.09.006.

Hansson, O; Zetterberg, H; Vanmechelen, E; Vanderstichele, H; Andreasson, U; Londos, E; Wallin, A; (2010) Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment. Neurobiol Aging , 31 (3) pp. 357-367. 10.1016/j.neurobiolaging.2008.03.027.

Hardell, L; Söderqvist, F; Carlberg, M; Zetterberg, H; Mild, KH; (2010) Exposure to wireless phone emissions and serum beta-trace protein. Int J Mol Med , 26 (2) pp. 301-306.

Hardingham, GE; Patani, R; Baxter, P; Wyllie, DJ; Chandran, S; (2010) Human embryonic stem cell-derived neurons as a tool for studying neuroprotection and neurodegeneration. Mol Neurobiol , 42 (1) pp. 97-102. 10.1007/s12035-010-8136-2.

Hardy, J; (2010) Genetic Analysis of Pathways to Parkinson Disease. NEURON , 68 (2) 201 - 206. 10.1016/j.neuron.2010.10.014. Gold open access

Hardy, J; (2010) Genetics of tauopathies. In: EUROPEAN NEUROPSYCHOPHARMACOLOGY. (pp. S163 - S163). ELSEVIER SCIENCE BV

Hardy, J; (2010) Neurological Diagnoses Identify Molecular Processes. ARCH NEUROL-CHICAGO , 67 (4) 400 - 401.

Hardy, J; (2010) Sample Tracking and Use in Published Genome-wide Association Studies. ARCH NEUROL-CHICAGO , 67 (10) 1267 - 1268.

Hardy, J; (2010) Whole Genome Analysis of Neurodegenerative Disease. In: CELL TRANSPLANTATION. (pp. 342 - 342). COGNIZANT COMMUNICATION CORP

Hardy, J; (2010) The genetics of parkinsonisms. In: JOURNAL OF NEUROLOGY. (pp. S8 - S8). SPRINGER HEIDELBERG

Hardy, J; Gwinn, K; (2010) Protected to Death. J ALZHEIMERS DIS , 20 (2) 409 - 413. 10.3233/JAD-2010-1416.

Hardy, J; Williams, J; (2010) Identification of Alzheimer Risk Factors Through Whole-Genome Analysis. ARCH NEUROL-CHICAGO , 67 (6) 663 - 664.

Heinzen, EL; Radtke, RA; Urban, TJ; Cavalleri, GL; Depondt, C; Need, AC; Walley, NM; (2010) Rare Deletions at 16p13.11 Predispose to a Diverse Spectrum of Sporadic Epilepsy Syndromes. The American Journal of Human Genetics , 86 (5) 707 - 718. 10.1016/j.ajhg.2010.03.018. Green open access

Hertze, J; Minthon, L; Zetterberg, H; Vanmechelen, E; Blennow, K; Hansson, O; (2010) Evaluation of CSF biomarkers as predictors of Alzheimer's disease: a clinical follow-up study of 4.7 years. J Alzheimers Dis , 21 (4) pp. 1119-1128.

Hilton-Jones, D; Miller, A; Parton, M; Holton, J; Sewry, C; Hanna, MG; (2010) Inclusion body myositis: MRC Centre for Neuromuscular Diseases, IBM workshop, London, 13 June 2008. Neuromuscul Disord , 20 (2) pp. 142-147. 10.1016/j.nmd.2009.11.003.

Houlden, H; Schneider, SA; Paudel, R; Melchers, A; Schwingenschuh, P; Edwards, M; Hardy, J; (2010) THAP1 mutations (DYT6) are an additional cause of early-onset dystonia. NEUROLOGY , 74 (10) 846 - 850.

Houlden, HP; Favaregh, AL; Hemsch, MJ; (2010) Quantification of the uncertainties for the Ares I A106 ascent aerodynamic database. 27th AIAA Aerodynamic Measurement Technology and Ground Testing Conference 2010

Houlston, RS; Cheadle, J; Dobbins, SE; Tenesa, A; Jones, AM; Howarth, K; Spain, SL; (2010) Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33. Nat Genet , 42 (11) pp. 973-977. 10.1038/ng.670.

Housden, CR; O'Sullivan, SS; Joyce, EM; Lees, AJ; Roiser, JP; (2010) Intact Reward Learning but Elevated Delay Discounting in Parkinson's Disease Patients With Impulsive-Compulsive Spectrum Behaviors. NEUROPSYCHOPHARMACOL , 35 (11) 2155 - 2164. 10.1038/npp.2010.84.

Hutton, EJ; Carty, L; Laura, M; Houlden, H; Lunn, MP; Brandner, S; Mirsky, R; (2010) C-Jun expression in human neuropathies: a pilot study. In: NEUROMUSCULAR DISORDERS. (pp. S22 - S22). PERGAMON-ELSEVIER SCIENCE LTD

Hébert, SS; Papadopoulou, AS; Smith, P; Galas, MC; Planel, E; Silahtaroglu, AN; Sergeant, N; (2010) Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration. Hum Mol Genet , 19 (20) pp. 3959-3969. 10.1093/hmg/ddq311.


Igosheva, N; Abramov, AY; Poston, L; Eckert, JJ; Fleming, TP; Duchen, MR; McConnell, J; (2010) Maternal Diet-Induced Obesity Alters Mitochondrial Activity and Redox Status in Mouse Oocytes and Zygotes. PLOS ONE , 5 (4) , Article e10074. 10.1371/journal.pone.0010074. Green open access

Innes, A; Kalmar, B; Houlden, H; Reilly, MM; Greensmith, L; (2010) Characterisation of novel mutations within HSP27 causing Charcot-Marie-Tooth disease 2F and distal hereditary motor neuropathy II. In: NEUROMUSCULAR DISORDERS. (pp. S21 - S22). PERGAMON-ELSEVIER SCIENCE LTD

International Stroke Genetics Consortium, ; Wellcome Trust Case-Control Consortium 2, ; (2010) Failure to validate association between 12p13 variants and ischemic stroke. N Engl J Med , 362 (16) pp. 1547-1550. 10.1056/NEJMc0910050.

Iovino, M; Patani, R; Watts, C; Chandran, S; Spillantini, MG; (2010) Human Stem Cell-Derived Neurons: A System to Study Human Tau Function and Dysfunction. PLoS One , 5 (11) , Article e13947. 10.1371/journal.pone.0013947. Green open access

Isaacs, JD; Adams, M; Lees, AJ; (2010) Noncompressive myelopathy associated with violent axial tics of tourette syndrome. Neurology , 74 (8) pp. 697-698. 10.1212/WNL.0b013e3181d0cc77.


Jahanshahi, M; Jones, CRG; Zijlmans, J; Katzenschlager, R; Lee, L; Quinn, N; Frith, CD; (2010) Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's disease. BRAIN , 133 727 - 745. 10.1093/brain/awq012.

Jelen, N; Ule, J; Zivin, M; (2010) Cholinergic regulation of striatal Nova mRNAs. Neuroscience , 169 (2) pp. 619-627. 10.1016/j.neuroscience.2010.05.013.

Johnson, JO; Gibbs, JR; Van Maldergem, L; Houlden, H; Singleton, AB; (2010) Exome Sequencing in Brown-Vialetto-Van Laere Syndrome. AM J HUM GENET , 87 (4) 567 - 569. 10.1016/j.ajhg.2010.05.021.

Jones, L; Holmans, PA; Hamshere, ML; Harold, D; Moskvina, V; Ivanov, D; Pocklington, A; (2010) Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease. PLOS ONE , 5 (11) , Article e13950. 10.1371/journal.pone.0013950. Green open access

Jonsson, M; Zetterberg, H; van Straaten, E; Lind, K; Syversen, S; Edman, A; Blennow, K; (2010) Cerebrospinal fluid biomarkers of white matter lesions - cross-sectional results from the LADIS study. Eur J Neurol , 17 (3) pp. 377-382. 10.1111/j.1468-1331.2009.02808.x.

Jorissen, E; De Strooper, B; (2010) Gamma-secretase and the intramembrane proteolysis of Notch. Curr Top Dev Biol , 92 pp. 201-230. 10.1016/S0070-2153(10)92006-1.

Jorissen, E; Prox, J; Bernreuther, C; Weber, S; Schwanbeck, R; Serneels, L; Snellinx, A; (2010) The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex. J Neurosci , 30 (14) pp. 4833-4844. 10.1523/JNEUROSCI.5221-09.2010.


Kagi, G; Klein, C; Wood, NW; Schneider, SA; Pramstaller, PP; Tadic, V; Quinn, NP; (2010) Nonmotor Symptoms in Parkin Gene-Related Parkinsonism. MOVEMENT DISORD , 25 (9) 1279 - 1284. 10.1002/mds.22897.

Kapoor, RR; Heslegrave, A; Hussain, K; (2010) Congenital Hyperinsulinism due to mutations in HNF4A and HADH. REV ENDOCR METAB DIS , 11 (3) 185 - 191. 10.1007/s11154-010-9148-y.

Kasperaviciute, D; Catarino, CB; Heinzen, EL; Depondt, C; Cavalleri, GL; Caboclo, LO; Tate, SK; (2010) Common genetic variation and susceptibility to partial epilepsies: a genome-wide association study. BRAIN , 133 2136 - 2147. 10.1093/brain/awq130.

Kay, V; Vandrovcova, J; Pittmann, A; Lees, A; de Silva, R; (2010) Tau gene polymorphism influences risk of sporadic tauopathy by allele-specific changes in transcription and alternative splicing. In: MOVEMENT DISORDERS. (pp. S475 - S475). WILEY-LISS

Kempster, PA; O'Sullivan, SS; Holton, JL; Revesz, T; Lees, AJ; (2010) Relationships between age and late progression of Parkinson's disease: a clinico-pathological study. BRAIN , 133 1755 - 1762. 10.1093/brain/awq059.

Kingsbury, AE; Bandopadhyay, R; Silveira-Moriyama, L; Ayling, H; Kallis, C; Sterlacci, W; Maeir, H; (2010) Brain Stem Pathology in Parkinson's Disease: An Evaluation of the Braak Staging Model. MOVEMENT DISORD , 25 (15) 2508 - 2515. 10.1002/mds.23305.

Kingsbury, AE; Bandopadhyay, R; Silveira-Moriyama, L; Ayling, H; Kallis, C; Sterlacci, W; Maeir, H; (2010) Brain stem pathology in Parkinson's disease: An evaluation of the Braak staging model. Movement Disorders , 25 (15) pp. 2508-2515. 10.1002/mds.23305.

Kruer, MC; Paisan-Ruiz, C; Boddaert, N; Yoon, MY; Hama, H; Gregory, A; Malandrini, A; (2010) Defective FA2H Leads to a Novel Form of Neurodegeneration with Brain Iron Accumulation (NBIA). ANN NEUROL , 68 (5) 611 - 618. 10.1002/ana.22122.

Kruer, MC; Paisan-Ruiz, C; Yoon, MY; Gregory, A; Woltjer, RL; Malandrini, A; Polster, BJ; (2010) Defective Fatty Acid Hydroxylase Leads to a Novel Subtype of Neurodegeneration with Brain Iron Accumulation (NBIA). In: ANNALS OF NEUROLOGY. (pp. S30 - S31).

Kruer, MC; Paisan-Ruiz, C; Yoon, MY; Hama, H; Gregory, A; Malandrini, A; Woltjer, RL; (2010) Mutation in FA2H leads to Fatty Acid Hydroxylase-associated Neurodegeneration (FAHN). In: ANNALS OF NEUROLOGY. (pp. S91 - S91).

Kuperstein, I; Broersen, K; Benilova, I; Rozenski, J; Jonckheere, W; Debulpaep, M; Vandersteen, A; (2010) Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio. EMBO J , 29 (19) pp. 3408-3420. 10.1038/emboj.2010.211.

König, J; Zarnack, K; Rot, G; Curk, T; Kayikci, M; Zupan, B; Turner, DJ; (2010) iCLIP reveals the function of hnRNP particles in splicing at individual nucleotide resolution. Nat Struct Mol Biol , 17 (7) pp. 909-915. 10.1038/nsmb.1838.


Landgren, S; Jerlhag, E; Hallman, J; Oreland, L; Lissner, L; Strandhagen, E; Thelle, DS; (2010) Genetic variation of the ghrelin signaling system in females with severe alcohol dependence. Alcohol Clin Exp Res , 34 (9) pp. 1519-1524. 10.1111/j.1530-0277.2010.01236.x.

Landgren, S; Palmér, MS; Skoog, I; Minthon, L; Wallin, A; Andreasen, N; Zetterberg, M; (2010) No association of VEGF polymorphims with Alzheimer's disease. Neuromolecular Med , 12 (3) pp. 224-228. 10.1007/s12017-009-8096-8.

Landoure, G; Zdebik, AA; Martinez, TL; Burnett, BG; Stanescu, HC; Inada, H; Shi, YJ; (2010) Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C. NAT GENET , 42 (2) 170 - U109. 10.1038/ng.512. Gold open access

Langbehn, DR; Hayden, MR; Paulsen, JS; PREDICT-HD Investigators of the Huntington Study Group, ; (2010) CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches. Am J Med Genet B Neuropsychiatr Genet , 153B (2) pp. 397-408. 10.1002/ajmg.b.30992.

Lashley, T; Rohrer, J; Bandopadhyay, R; Ahmed, Z; Borroni, B; Warren, J; Troakes, C; (2010) Frontotemporal lobar degeneration with FUS-positive inclusions. In: BRAIN PATHOLOGY. (pp. 24 - 24). WILEY-BLACKWELL PUBLISHING, INC

Lau, P; de Strooper, B; (2010) Dysregulated microRNAs in neurodegenerative disorders. Semin Cell Dev Biol , 21 (7) pp. 768-773. 10.1016/j.semcdb.2010.01.009.

Lees, A; (2010) Clinical Neuropathologic Correlation. MOVEMENT DISORDERS , 25 S575 - S575.

Lees, AJ; (2010) Chronic manganism clinical features and causes. In: EUROPEAN JOURNAL OF NEUROLOGY. (pp. 633 - 633).

Lees, AJ; (2010) Expanding the links between Brazilian and British neurology. Arq Neuropsiquiatr , 68 (4) pp. 493-494. Gold open access

Limongelli, G; Rahman, S; Pitceathly, RDS; Hanna, MG; Elliott, PM; (2010) Cardiac manifestations of mitochondrial disorders reply. EUR J HEART FAIL , 12 (6) 637 - 638. 10.1093/eurjhf/hfq046.

Limongelli, G; Tome-Esteban, M; Dejthevaporn, C; Rahman, S; Hanna, MG; Elliott, PM; (2010) Prevalence and natural history of heart disease in adults with primary mitochondrial respiratory chain disease. EUR J HEART FAIL , 12 (2) 114 - 121. 10.1093/eurjhf/hfp186.

Limongelli, G; Tome-Esteban, M; Dejthevaporn, C; Rahman, S; Hanna, MG; Elliott, PM; (2010) Prevalence and natural history of heart disease in adults with primary mitochondrial respiratory chain disease (vol 12, pg 114, 2010). EUROPEAN JOURNAL OF HEART FAILURE , 12 (9) p. 1017. 10.1093/eurjhf/hfq143.

Lindgren, HS; O'Sullivan, SS; Lees, AJ; Cenci, MA; (2010) Immunohistochemical Detection of Fosb/Delta fosb-Like Proteins Maps Areas of Maladaptive Neuroplasticity in the Post-Mortem Parkinsonian Brain. MOVEMENT DISORDERS , 25 S673-S673.

Ling, H; Braschinsky, M; Taba, P; Luus, S; Lees, A; (2010) A decade of delayed diagnosis in two cases of monogenetic parkinsonism. In: MOVEMENT DISORDERS. (pp. S358 - S358).

Ling, H; Lees, AJ; (2010) How can neuroimaging help in the diagnosis of movement disorders? Neuroimaging Clin N Am , 20 (1) pp. 111-123. 10.1016/j.nic.2009.08.004.

Ling, H; Massey, L; Lees, A; Brown, P; Schwingenschuh, P; Bhatia, K; Day, BL; (2010) Bradykinesia in Parkinson's disease and related conditions. In: MOVEMENT DISORDERS. (pp. S358 - S359).

Ling, H; Massey, LM; Lees, AJ; Brown, P; Schwingenschuh, P; Bhatia, K; Day, BL; (2010) Bradykinesia in Parkinson's Disease and Related Conditions. MOVEMENT DISORDERS , 25 S641 - S642.

Ling, H; O'Sullivan, SS; Holton, JL; Revesz, T; Massey, LA; Williams, DR; Paviour, DC; (2010) Does corticobasal degeneration exist? A clinicopathological re-evaluation. Brain , 133 (7) pp. 2045-2057. 10.1093/brain/awq123.

Ling, HL; O'Sullivan, SS; Holton, JL; Revesz, T; Massey, LA; Williams, DR; Paviour, DC; (2010) Does corticobasal degeneration exist? A clinicopathological re-evaluation. BRAIN , 133 2045 - 2057. 10.1093/brain/awq123.

Luigetti, M; Pizzuti, A; Bartoletti, S; Houlden, H; Pirro, C; Bottillo, I; Madia, F; (2010) Triple A syndrome: A novel compound heterozygous mutation in the AAAS gene in an Italian patient without adrenal insufficiency. J NEUROL SCI , 290 (1-2) 150 - 152. 10.1016/j.jns.2009.12.005.

Luk, C; Vandrovcova, J; Malzer, E; Lees, A; de Silva, R; (2010) BRAIN TAU ISOFORM mRNA AND PROTEIN CORRELATION IN PSP BRAIN. TRANSLATIONAL NEUROSCIENCE , 1 (1) pp. 30-36. 10.2478/v10134-010-0009-8.


Machado, P; Coutinho, M; da Silva, JA; (2010) Selecting men for bone densitometry: performance of osteoporosis risk assessment tools in Portuguese men. Osteoporos Int , 21 (6) pp. 977-983. 10.1007/s00198-009-1036-5.

Machado, P; Landewé, R; Braun, J; Hermann, KG; Baker, D; van der Heijde, D; (2010) Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis. Ann Rheum Dis , 69 (8) pp. 1465-1470. 10.1136/ard.2009.124206.

Maloney, B; Ge, YW; Petersen, RC; Hardy, J; Rogers, JT; Perez-Tur, J; Lahiri, DK; (2010) Functional Characterization of Three Single-Nucleotide Polymorphisms Present in the Human APOE Promoter Sequence: Differential Effects in Neuronal Cells and on DNA-Protein Interactions. AM J MED GENET B , 153B (1) 185 - 201. 10.1002/ajmg.b.30973.

Maloney, B; Ge, YW; Petersen, RC; Hardy, J; Rogers, JT; Pérez-Tur, J; Lahiri, DK; (2010) Functional characterization of three single-nucleotide polymorphisms present in the human APOε promoter sequence: Differential effects in neuronal cells and on DNA-protein interactions. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics , 153 (1) pp. 185-201. 10.1002/ajmg.b.30973.

Mamais, A.; (2010) Investigation of an N5-glutamine methyltranferase, a novel partner of α2-chimaerin. Doctoral thesis, UCL (University College London). Green open access


Massey, LA; Micallef, CD; Paviour, DC; O'Sullivan, SS; Burn, DJ; Holton, JL; Revesz, TA; (2010) Blinded analysis of conventional MR images in a cohort of pathologically confirmed parkinsonian illnesses at the QSBB. In: MOVEMENT DISORDERS. (pp. S386 - S387).

Massey, LA; Sinclair, CD; Mancini, LC; White, MJ; Thornton, JS; Lees, AJ; Yousry, TA; (2010) A multimodal assessment of the brainstem using 3T MRI in PSP and PD. In: MOVEMENT DISORDERS. (pp. S386 - S386). WILEY-LISS

Matarin, M; Singleton, A; Hardy, J; Meschia, J; (2010) The genetics of ischaemic stroke. In: JOURNAL OF INTERNAL MEDICINE. (pp. 139 - 155). WILEY-BLACKWELL PUBLISHING, INC

Matsuki, T; Matthews, RT; Cooper, JA; van der Brug, MP; Cookson, MR; Hardy, JA; Olson, EC; (2010) Reelin and stk25 have opposing roles in neuronal polarization and dendritic Golgi deployment. Cell , 143 (5) pp. 826-836. 10.1016/j.cell.2010.10.029.

Matthews, E; Fialho, D; Tan, SV; Venance, SL; Cannon, SC; Sternberg, D; Fontaine, B; (2010) The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment. BRAIN , 133 9 - 22. 10.1093/brain/awp294. Gold open access

Matthews, E; Hanna, MG; (2010) Muscle channelopathies: does the predicted channel gating pore offer new treatment insights for hypokalaemic periodic paralysis? J PHYSIOL-LONDON , 588 (11) 1879 - 1886. 10.1113/jphysiol.2009.186627. Gold open access

Matthews, E; Sud, R; Labrum, R; Strycharczuk, L; Sinclair, CDJ; Yousry, TA; Hanna, MG; (2010) Using MRI as a diagnostic tool in the skeletal muscle channelopathies. In: NEUROMUSCULAR DISORDERS. (pp. S29 - S30). PERGAMON-ELSEVIER SCIENCE LTD

Mattsson, N; Blennow, K; Zetterberg, H; (2010) Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fall. Clin Chem Lab Med , 48 (5) pp. 603-607. 10.1515/CCLM.2010.131.

Mattsson, N; Brax, D; Zetterberg, H; (2010) To know or not to know: ethical issues related to early diagnosis of Alzheimer's disease. Int J Alzheimers Dis , 2010 10.4061/2010/841941.

Mattsson, N; Bremell, D; Anckarsäter, R; Blennow, K; Anckarsäter, H; Zetterberg, H; Hagberg, L; (2010) Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism. BMC Neurol , 10 51-. 10.1186/1471-2377-10-51.

Mattsson, N; Johansson, P; Hansson, O; Wallin, A; Johansson, JO; Andreasson, U; Andersen, O; (2010) Converging pathways of chromogranin and amyloid metabolism in the brain. J Alzheimers Dis , 20 (4) pp. 1039-1049. 10.3233/JAD-2010-091651.

Mattsson, N; Sävman, K; Osterlundh, G; Blennow, K; Zetterberg, H; (2010) Converging molecular pathways in human neural development and degeneration. Neurosci Res , 66 (3) pp. 330-332. 10.1016/j.neures.2009.11.012.

Mattsson, N; Zetterberg, H; (2010) Cerebrospinal fluid biomarkers for vascular dementia. Minerva Psichiatrica , 51 (1) pp. 37-41.

Mattsson, N; Zetterberg, H; Blennow, K; (2010) Lessons from Multicenter Studies on CSF Biomarkers for Alzheimer's Disease. Int J Alzheimers Dis , 2010 10.4061/2010/610613.

Mead, S; Gandhi, S; Carswell, C; Ayling, H; Beck, J; Caine, D; Gallujipali, D; (2010) Novel Truncation Mutation of PRNP Causes Chronic Diarrhoea, Sensory Neuropathy and Autonomic Failure Associated with Prion Protein Deposition in the Cerebral Blood Vessels and Small Bowel. PRION , 4 (3) 201 - 202.



Miller, AD; Ahmed, M; Hanna, MG; Greensmith, L; (2010) Augmentation of the heat shock response in an in vitro model of sporadic inclusion body myositis. In: NEUROMUSCULAR DISORDERS. (pp. S26 - S27). PERGAMON-ELSEVIER SCIENCE LTD

Moglia, C; Calvo, A; Lai, SL; Abramzon, Y; Schymick, JC; Guerreiro, RJ; Stephan, DA; (2010) FUS Mutations in a Large Series of Sporadic and Familial ALS. In: NEUROLOGY. (pp. A334 - A334). LIPPINCOTT WILLIAMS & WILKINS

Momeni, P; DeTucci, K; Straub, RE; Weinberger, DR; Davies, P; Grafman, J; Hardy, J; (2010) Progranulin (GRN) in two siblings of a Latino family and in other patients with Schizophrenia. NEUROCASE , 16 (3) 273 - 279. 10.1080/13554790903456209.

Momeni, P; Wickremaratchi, MM; Bell, J; Arnold, R; Beer, R; Hardy, J; Revesz, T; (2010) Familial early onset frontotemporal dementia caused by a novel S356T MAPT mutation, initially diagnosed as schizophrenia. CLIN NEUROL NEUROSUR , 112 (10) 917 - 920. 10.1016/j.clineuro.2010.07.015.

Morais, VA; De Strooper, B; (2010) Mitochondria dysfunction and neurodegenerative disorders: cause or consequence. J Alzheimers Dis , 20 Sup S255-S263. 10.3233/JAD-2010-100345.

Morley, JF; Cohen, A; Silveira-Moriyama, L; Williams, DR; Katenzschlager, R; Moberg, P; Hower, R; (2010) Developing a better UPSIT for PD. In: MOVEMENT DISORDERS. (pp. S349 - S349). WILEY-LISS

Moscovich, M; Munhoz, RP; Teive, HA; Raskin, S; Carvalho, MJ; Barbosa, ER; Ranvaud, R; (2010) Olfactory impairment in patients with spinocerebellar ataxias (SCA). In: MOVEMENT DISORDERS. (pp. S195 - S195). WILEY-LISS

Munhoz, RP; Eleftherohorinou, H; Teive, HHA; Coin, LJ; Werneck, LC; Lees, AJ; Silveira-Moriyama, L; (2010) Predicting non-motor features of Parkinson's disease. In: MOVEMENT DISORDERS. (pp. S360 - S360). WILEY-LISS

Munhoz, RP; Teive, HA; Eleftherohorinou, H; Coin, LJ; Lees, A; Werneck, L; Silveira-Moriyama, L; (2010) Can Motor Features of Parkinson's Disease Be Used To Predict Occurrence of Non-Motor Symptoms of the Disease? In: NEUROLOGY. (pp. A300 - A300). LIPPINCOTT WILLIAMS & WILKINS

Murphy, S; Brandner, S; Polke, J; Manji, H; Houlden, H; Reilly, MM; (2010) A NOVEL MUTATION IN THE NERVE-SPECIFIC 5 '-UTR OF THE CX32 GENE CAUSING CMTX1. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , 81 (11) E50 - E50. 10.1136/jnnp.2010.226340.133.

Murphy, SM; Counihan, T; (2010) Cerebrovascular disorders. In: Andreoli, TE and Benjamin, IJ and Griggs, RC and Wing, EJ, (eds.) Andreoli and Carpenter's Cecil essentials of medicine. (pp. 1123-1135). Saunders Elsevier: Philadelphia.

Murphy, SM; Counihan, T; (2010) Cortical syndromes. In: Andreoli, TE and Benjamin, IJ and Griggs, RC and Wing, EJ, (eds.) Andreoli and Carpenter's Cecil essentials of medicine. (pp. 1068-1071). Saunders Elsevier: Philadelphia.

Murphy, SM; Polke, JM; Manji, H; Brandner, S; Houlden, H; Reilly, MM; (2010) A novel mutation in the nerve-specific 5 ' UTR of the Cx32 gene causing CMTX1. In: NEUROMUSCULAR DISORDERS. (pp. S20 - S21). PERGAMON-ELSEVIER SCIENCE LTD

Männikkö, R; Jefferies, C; Flanagan, SE; Hattersley, A; Ellard, S; Ashcroft, FM; (2010) Interaction between mutations in the slide helix of Kir6.2 associated with neonatal diabetes and neurological symptoms. Hum Mol Genet , 19 (6) pp. 963-972. 10.1093/hmg/ddp554.

Männikkö, R; Overend, G; Perrey, C; Gavaghan, CL; Valentin, JP; Morten, J; Armstrong, M; (2010) Pharmacological and electrophysiological characterization of nine, single nucleotide polymorphisms of the hERG-encoded potassium channel. Br J Pharmacol , 159 (1) pp. 102-114. 10.1111/j.1476-5381.2009.00334.x.


Nicaretta, DH; Rosso, ALZ; Mattos, JP; Brandao, L; Pimentel, MLV; Cunha, FC; Novis, SAP; (2010) Dystonia induced by peripheral trauma: Organic or psychogenic? In: MOVEMENT DISORDERS. (pp. S245 - S245).

Nilsson, T; Bromander, S; Anckarsäter, R; Kristiansson, M; Forsman, A; Blennow, K; Zetterberg, H; (2010) Neurochemical measures co-vary with personality traits: forensic psychiatric findings replicated in a general population sample. Psychiatry Res , 178 (3) pp. 525-530. 10.1016/j.psychres.2010.05.016.

Nopoulos, PC; Aylward, EH; Ross, CA; Johnson, HJ; Magnotta, VA; Juhl, AR; Pierson, RK; (2010) Cerebral cortex structure in prodromal Huntington disease. Neurobiol Dis , 40 (3) pp. 544-554. 10.1016/j.nbd.2010.07.014.


Novak, MJU; Sweeney, MG; Li, A; Treacy, C; Chandrashekar, HS; Giunti, P; Goold, RG; (2010) An ITPR1 Gene Deletion Causes Spinocerebellar Ataxia 15/16: A Genetic, Clinical and Radiological Description. MOVEMENT DISORD , 25 (13) 2176 - 2182. 10.1002/mds.23223.

Novak, MJU; Tabrizi, SJ; (2010) Huntington's disease. In: UNSPECIFIED (? - ?). B M J PUBLISHING GROUP

Noyce, AJ; McCrae, S; Gawler, J; Evanson, J; (2010) Teaching NeuroImages: microhemorrhages resulting from cranial radiotherapy in childhood. Neurology , 75 (1) e2-e3. 10.1212/WNL.0b013e3181e620df.

Nyhlén, J; Constantinescu, R; Zetterberg, H; (2010) Problems associated with fluid biomarkers for Parkinson's disease. Biomark Med , 4 (5) pp. 671-681. 10.2217/bmm.10.84.


O'Sullivan, S.S.; (2010) Non-motor symptons in Parkinson's disease including the dopamine dysregulation syndrome and impulse control. Doctoral thesis, UCL (University College London).

O'Sullivan, SS; Djamshidian, A; Ahmed, Z; Evans, AH; Lawrence, AD; Holton, JL; Revesz, T; (2010) Impulsive-Compulsive Spectrum Behaviors in Pathologically Confirmed Progressive Supranuclear Palsy. MOVEMENT DISORD , 25 (5) 638 - 642. 10.1002/mds.22902.

O'Sullivan, SS; Djamshidian, A; Evans, A; Fitzroy, N; Loane, CM; Lees, AJ; Lawrence, AD; (2010) Excessive Hoarding in Parkinson's Disease. In: NEUROLOGY. (pp. A331 - A331). LIPPINCOTT WILLIAMS & WILKINS

O'Sullivan, SS; Djamshidian, A; Evans, AH; Loane, CM; Lees, AJ; Lawrence, AD; (2010) Excessive Hoarding in Parkinson's Disease. MOVEMENT DISORD , 25 (8) 1026 - 1033. 10.1002/mds.23016.

O'Sullivan, SS; Evans, AH; Quinn, NP; Lawrence, AD; Lees, AJ; (2010) Reckless Generosity in Parkinson's Disease. MOVEMENT DISORD , 25 (2) 221 - 223. 10.1002/mds.22687.

O'Sullivan, SS; Johnson, M; Williams, DR; Revesz, T; Holton, JL; Lees, AJ; Perry, EK; (2010) The effect of drug treatment on neurogenesis in Parkinson's disease. Mov Disord 10.1002/mds.23340.

O'Sullivan, SS; Loane, CM; Lawrence, AD; Evans, AH; Piccini, P; Lees, AJ; (2010) Sleep Disturbance, Dreams, Mood and Impulsive-Compulsive Behaviours in Parkinson's Disease. In: NEUROLOGY. (pp. A279 - A279).

Ozawa, T; Holton, JL; Paviour, D; Lees, AJ; Tada, M; Kakita, A; Onodera, O; (2010) Disequilibrium in MSA phenotype distribution between populations: genetics or environment? In: BRAIN PATHOLOGY. (pp. 29 - 29). WILEY-BLACKWELL PUBLISHING, INC


Paisan-Ruiz, C; Guevara, R; Federoff, M; Hanagasi, H; Sina, F; Elahi, E; Schneider, SA; (2010) Early-Onset L-dopa-Responsive Parkinsonism with Pyramidal Signs Due to ATP13A2, PLA2G6, FBXO7 and Spatacsin Mutations. MOVEMENT DISORD , 25 (12) 1791 - 1800. 10.1002/mds.23221.

Paisan-Ruiz, C; Houlden, H; (2010) Common pathogenic pathways in melanoma and Parkinson disease. NEUROLOGY , 75 (18) 1653 - 1655.

Paisán-Ruiz, C; Guevara, R; Federoff, M; Hanagasi, H; Sina, F; Elahi, E; Schneider, SA; (2010) Early-onset L-dopa-responsive Parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and Spatacsin mutations. Movement Disorders , 25 (12) pp. 1791-1800. 10.1002/mds.23221.

Paisán-Ruiz, C; Li, A; Schneider, S; Holton, JL; Johnson, R; Kidd, D; Chataway, J; (2010) Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations. Neurobiology of Aging

Parkkinen, L; O'Sullivan, SS; Kuoppamaki, M; Collins, C; Holton, JL; Revesz, T; Lees, AJ; (2010) Does L-dopa have toxic effects in Parkinson's disease brain? In: MOVEMENT DISORDERS. (pp. S418 - S418). WILEY-LISS

Parkkinen, L; O'sullivan, S; Kuoppamaki, M; Collins, C; Kallis, C; Holton, JL; Revesz, T; (2010) Does Levodopa Affect Progression of Neuropathology in Parkinson's Disease? A Clinico-Pathological Study. MOVEMENT DISORD , 25 S629 - S629.

Parton, M; Hanna, MG; Miller, AD; Morrow, JM; (2010) IBM-Net: a clinical database of inclusion body myositis patients. In: NEUROMUSCULAR DISORDERS. (pp. S27 - S27). PERGAMON-ELSEVIER SCIENCE LTD

Paulsen, JS; Nopoulos, PC; Aylward, E; Ross, CA; Johnson, H; Magnotta, VA; Juhl, A; (2010) Striatal and white matter predictors of estimated diagnosis for Huntington disease. Brain Res Bull , 82 (3-4) pp. 201-207. 10.1016/j.brainresbull.2010.04.003.

Paulsen, JS; Wang, C; Duff, K; Barker, R; Nance, M; Beglinger, L; Moser, D; (2010) Challenges assessing clinical endpoints in early Huntington disease. Mov Disord , 25 (15) pp. 2595-2603. 10.1002/mds.23337.

Pavese, N; Moore, RY; Scherfler, C; Khan, NL; Hotton, G; Quinn, NP; Bhatia, KP; (2010) In vivo assessment of brain monoamine systems in parkin gene carriers: A PET study. EXP NEUROL , 222 (1) 120 - 124. 10.1016/j.expneurol.2009.12.021.

Pavlov, E; Aschar-Sobbi, R; Campanella, M; Turner, RJ; Gomez-Garcia, MR; Abramov, AY; (2010) Inorganic Polyphosphate and Energy Metabolism in Mammalian Cells. J BIOL CHEM , 285 (13) 9420 - 9428. 10.1074/jbc.M109.013011. Gold open access

Penno, A; Reilly, MM; Houlden, H; Laura, M; Rentsch, K; Niederkofler, V; Stoeckli, ET; (2010) Hereditary Sensory Neuropathy Type 1 Is Caused by the Accumulation of Two Neurotoxic Sphingolipids. J BIOL CHEM , 285 (15) 11178 - 11187. 10.1074/jbc.M109.092973. Gold open access

Pitceathly, R; McFarland, R; Nesbitt, V; Rahman, S; Hanna, MG; Turnbull, DM; (2010) MRC MITOCHONDRIAL COHORT STUDY: DEVELOPMENT OF A UK DATABASE. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , 81 (11) E66 - E67. 10.1136/jnnp.2010.226340.198.

Pitceathly, RDS; Holton, JL; Hargreaves, I; Heales, S; Woodward, C; Sweeney, MG; Davis, MB; (2010) Novel POLG mutation causing distal myopathy and cachexia. In: JOURNAL OF MEDICAL GENETICS. (pp. S54 - S54). B M J PUBLISHING GROUP

Pitceathly, RDS; Holton, JL; Miller, JAL; Quinlivan, R; Hanna, MG; (2010) The expanding histopathological profile of the myofibrillar myopathies. In: NEUROMUSCULAR DISORDERS. (pp. S28 - S28). PERGAMON-ELSEVIER SCIENCE LTD

Pitceathly, RDS; Nesbitt, V; Rahman, S; McFarland, R; Hanna, MG; Turnbull, DM; (2010) MRC mitochondrial cohort study: development of a UK database. In: NEUROMUSCULAR DISORDERS. (pp. S23 - S23). PERGAMON-ELSEVIER SCIENCE LTD

Pitceathly, RDS; Woodward, CE; Mudanohwo, EE; Sweeney, MG; Davis, MB; Hanna, MG; Rahman, S; (2010) Non-invasive diagnosis of single deletion disorders in children with suspected mitochondrial disease. In: NEUROMUSCULAR DISORDERS. (pp. S24 - S24). PERGAMON-ELSEVIER SCIENCE LTD

Pittman, AM; Naranjo, S; Jalava, SE; Twiss, P; Ma, Y; Olver, B; Lloyd, A; (2010) Allelic variation at the 8q23.3 colorectal cancer risk locus functions as a cis-acting regulator of EIF3H. PLoS Genet , 6 (9) , Article e1001126. 10.1371/journal.pgen.1001126. Green open access

Plun-Favreau, H; Lewis, PA; Hardy, J; Martins, LM; Wood, NW; (2010) Cancer and neurodegeneration: between the devil and the deep blue sea. PLoS Genetics , 6 (12) , Article e1001257. 10.1371/journal.pgen.1001257. Green open access

Portaro, S; Matthews, E; Sud, R; Davis, MB; Hanna, MG; (2010) Acetazolamide response in patients affected by hypokalemic periodic paralysis. In: NEUROMUSCULAR DISORDERS. (pp. S16 - S16). PERGAMON-ELSEVIER SCIENCE LTD

Portelius, E; Andreasson, U; Ringman, JM; Buerger, K; Daborg, J; Buchhave, P; Hansson, O; (2010) Distinct cerebrospinal fluid amyloid beta peptide signatures in sporadic and PSEN1 A431E-associated familial Alzheimer's disease. Mol Neurodegener , 5 2-. 10.1186/1750-1326-5-2. Gold open access

Portelius, E; Bogdanovic, N; Gustavsson, MK; Volkmann, I; Brinkmalm, G; Zetterberg, H; Winblad, B; (2010) Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer's disease. Acta Neuropathol , 120 (2) pp. 185-193. 10.1007/s00401-010-0690-1.

Portelius, E; Brinkmalm, G; Tran, A; Andreasson, U; Zetterberg, H; Westman-Brinkmalm, A; Blennow, K; (2010) Identification of novel N-terminal fragments of amyloid precursor protein in cerebrospinal fluid. Exp Neurol , 223 (2) pp. 351-358. 10.1016/j.expneurol.2009.06.011.

Portelius, E; Dean, RA; Gustavsson, MK; Andreasson, U; Zetterberg, H; Siemers, E; Blennow, K; (2010) A novel Abeta isoform pattern in CSF reflects gamma-secretase inhibition in Alzheimer disease. Alzheimers Res Ther , 2 (2) 7-. 10.1186/alzrt30.

Portelius, E; Van Broeck, B; Andreasson, U; Gustavsson, MK; Mercken, M; Zetterberg, H; Borghys, H; (2010) Acute effect on the Aβ isoform pattern in CSF in response to γ-secretase modulator and inhibitor treatment in dogs. J Alzheimers Dis , 21 (3) pp. 1005-1012. 10.3233/JAD-2010-100573.

Pressey, SNR; O'Donnell, KJ; Stauber, T; Fuhrmann, JC; Tyynela, J; Jentsch, TJ; Cooper, JD; (2010) Distinct Neuropathologic Phenotypes After Disrupting the Chloride Transport Proteins ClC-6 or ClC-7/Ostm1. J NEUROPATH EXP NEUR , 69 (12) 1228 - 1246. 10.1097/NEN.0b013e3181ffe742.


Racca, C; Gardiol, A; Eom, T; Ule, J; Triller, A; Darnell, RB; (2010) The Neuronal Splicing Factor Nova Co-Localizes with Target RNAs in the Dendrite. Front Neural Circuits , 4 5-. 10.3389/neuro.04.005.2010. Gold open access

Rajakulendran, S; Graves, TD; Labrum, RW; Kotzadimitriou, D; Eunson, L; Davis, MB; Davies, R; (2010) Genetic and functional characterisation of the P/Q calcium channel in episodic ataxia with epilepsy. J PHYSIOL-LONDON , 588 (11) 1905 - 1913. 10.1113/jphysiol.2009.186437.

Rajakulendran, S; Kuntzer, T; Dunand, M; Yau, SC; Ashton, EJ; Storey, H; McCauley, J; (2010) Marked Hemiatrophy in Carriers of Duchenne Muscular Dystrophy. ARCH NEUROL-CHICAGO , 67 (4) 497 - 500.

Rajakulendran, S; Labrum, RW; Graves, TD; Tomlinson, S; Eunson, LH; Davis, MB; Schorge, S; (2010) CLINICAL AND GENETIC SPECTRUM OF THE EPISODIC ATAXIAS: THE UK PERSPECTIVE. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , 81 (11) E32 - E32. 10.1136/jnnp.2010.226340.59.

Rajakulendran, S; Matthews, E; Graves, TD; Tan, SV; Dewar, L; Griggs, RC; Hanna, MG; (2010) NATURAL HISTORY TRIALS OF NEUROLOGICAL CHANNELOPATHIES. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , 81 (11) ? - ?. 10.1136/jnnp.2010.226340.129.

Rajakulendran, S; Matthews, E; Tan, SV; Dewar, L; Griggs, RC; Hanna, MG; CINCH Grp, ; (2010) The genetic skeletal muscle channelopathies: genotype-phenotype correlation and longitudinal studies. In: NEUROMUSCULAR DISORDERS. (pp. S16 - S17). PERGAMON-ELSEVIER SCIENCE LTD

Rajakulendran, S; Parton, M; Holton, JL; Hanna, MG; (2010) Clinical and pathological heterogeneity in partial merosin deficiency. In: NEUROMUSCULAR DISORDERS. (pp. S11 - S11). PERGAMON-ELSEVIER SCIENCE LTD

Rajakulendran, S; Schorge, S; Kullmann, DM; Hanna, MG; (2010) Dysfunction of the Ca(V)2.1 calcium channel in cerebellar ataxias. F1000 Biol Rep , 2 10.3410/B2-4.

Rajakulendran, S; Tan, SV; Hanna, MG; (2010) Muscle weakness, palpitations and a small chin: the Andersen-Tawil syndrome. Pract Neurol , 10 (4) pp. 227-231. 10.1136/jnnp.2010.217794.

Ramiro, S; Machado, P; Singh, JA; Landewé, RB; da Silva, JA; (2010) Applying science in practice: the optimization of biological therapy in rheumatoid arthritis. Arthritis Res Ther , 12 (6) 220-. 10.1186/ar3149.

Rayan, DLR; Hanna, MG; (2010) Skeletal muscle channelopathies: nondystrophic myotonias and periodic paralysis. CURR OPIN NEUROL , 23 (5) 466 - 476. 10.1097/WCO.0b013e32833cc97e.

Rayan, DR; Matthews, E; Barreto, G; Tan, SV; Dewar, L; Burge, J; Hanna, MG; (2010) Double-blind placebo controlled cross-over study to investigate the efficacy of mexiletine in patients with non-dystrophic myotonia in the UK. In: NEUROMUSCULAR DISORDERS. (pp. S17 - S17). PERGAMON-ELSEVIER SCIENCE LTD

Renton, A.E.M.; (2010) Gene expression and genetic analyses in Parkinson’s disease with and without dementia. Doctoral thesis, UCL (University College London). Green open access

Revesz, T; Lashley, T; Ahmed, Z; Rohrer, J; Warren, J; Al-Saraj, S; Fox, N; (2010) The Spectrum of FUS-Positive Pathology in Frontotemporal Lobar Degenerations. In: JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. (pp. 552 - 552). LIPPINCOTT WILLIAMS & WILKINS

Revesz, T; Schott, JM; Holton, JL; Reiniger, L; Brandner, S; Thom, M; Warren, JD; (2010) Brain biopsy in dementia - clinical indications and diagnostic approach. In: BRAIN PATHOLOGY. (pp. 8 - 8). WILEY-BLACKWELL PUBLISHING, INC

Ribeiro, A; Machado, P; Ramiro, S; Duarte, C; Mourão, AF; Bogas, M; Costa, L; (2010) [Portuguese recommendations on "How to diagnose, monitor, and treat undifferentiated peripheral arthritis": systematic review of the literature and the experts' opinion]. Acta Reumatol Port , 35 (5) pp. 475-496.

Rodriguez-Violante, M; Lees, AJ; Cervantes-Arriaga, A; Corona, T; Silveira-Moriyama, L; (2010) Use of smell test identification in Parkinson's disease in Mexico. In: MOVEMENT DISORDERS. (pp. S350 - S350). WILEY-LISS

Rohrer, JD; Lashley, T; Mead, S; Fox, N; Holton, J; Revesz, T; Rossor, M; (2010) An Anatomopathological Classification of Frontotemporal Lobar Degeneration. In: NEUROLOGY. (pp. A132 - A133). LIPPINCOTT WILLIAMS & WILKINS

Rohrer, JD; Paviour, D; Bronstein, AM; O'sullivan, SS; Lees, A; Warren, JD; (2010) Progressive Supranuclear Palsy Syndrome Presenting as Progressive Nonfluent Aphasia: A Neuropsychological and Neuroimaging Analysis. MOVEMENT DISORD , 25 (2) 179 - 188. 10.1002/mds.22946.

Rolstad, S; Nordlund, A; Eckerström, C; Gustavsson, MH; Blennow, K; Olesen, PJ; Zetterberg, H; (2010) High education may offer protection against tauopathy in patients with mild cognitive impairment. J Alzheimers Dis , 21 (1) pp. 221-228. 10.3233/JAD-2010-091012.

Rosser, GJ; Reitböck, PG; Gray, MC; Warwicker, P; (2010) Successful stabilisation of nephropathy in a patient with POEMS (polyneuropathy, organomegaly, endocrinopathy, M-band, skin changes) syndrome on treatment with mycophenolate and steroids: a case report. J Med Case Rep , 4 63-. 10.1186/1752-1947-4-63.

Rostagno, A; Holton, JL; Lashley, T; Revesz, T; Ghiso, J; (2010) Cerebral amyloidosis: amyloid subunits, mutants and phenotypes. CELL MOL LIFE SCI , 67 (4) 581 - 600. 10.1007/s00018-009-0182-4.

Rowe, KC; Paulsen, JS; Langbehn, DR; Duff, K; Beglinger, LJ; Wang, C; O'Rourke, JJ; (2010) Self-paced timing detects and tracks change in prodromal Huntington disease. Neuropsychology , 24 (4) pp. 435-442. 10.1037/a0018905.

Russo, M; Laura, M; Polke, J; Davis, MB; Blake, J; Bradner, S; Hughes, RA; (2010) Variable phenotypes are associated with pmp22 missense mutations. In: JOURNAL OF NEUROLOGY. (pp. S40 - S40). SPRINGER HEIDELBERG

Russou, M; Laura, M; Polke, JM; Davis, MB; Blake, J; Bradner, S; Houlden, H; (2010) Diverse phenotypes are associated with missense mutations in the peripheral myelin protein 22 gene. In: NEUROMUSCULAR DISORDERS. (pp. S21 - S21). PERGAMON-ELSEVIER SCIENCE LTD

Ryan, D; Murphy, S; Hennessy, M; (2010) Bilateral posterior cerebral artery infarction. [Digital scholarly resource]. (In press).

Rylander, D; Parent, M; O'Sullivan, SS; Dovero, S; Lees, AJ; Bezard, E; Descarries, L; (2010) Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia. Ann Neurol , 68 (5) pp. 619-628. 10.1002/ana.22097.


Saidha, S; Murphy, S; McCartthy, P; Mayne, PD; Hennessy, M; (2010) L-2-hydroxyglutaric aciduria diagnosed in an adult presenting with acute deterioration. Journal of Neurology , 247 pp. 146-148. 10.1007/s00415-009-5319-8.

Saidha, S; Murphy, S; Ronayne, A; McCarthy, P; Hennessy, MJ; Counihan, T; (2010) Treatment of anti-glutamic acid decarboxylase antibody-associated limbic encephalitis with mycophenolate mofetil. Journal of Neurology , 257 pp. 1035-1038. 10.1007/s00415-010-5476-9.

Saifee, T; Lees, AJ; Silveira-Moriyama, L; (2010) Olfactory function in Parkinson's disease in ON versus OFF states. J NEUROL NEUROSUR PS , 81 (11) 1293 - 1295. 10.1136/jnnp.2009.182022.

Sailer, A; Kurzawa, M; Chinnery, PF; McKeith, IG; Morris, CM; Houlden, H; (2010) The SNCA locus in dementia with Lewy bodies. In: MOVEMENT DISORDERS. (pp. S488 - S488). WILEY-LISS

Sailer, A; Paisa-Puiz, C; Li, A; Paudel, R; Scholz, SW; Ahmed, Z; Revesz, T; (2010) Genetic analysis of the MAPT locus in multiple system atrophy. In: EUROPEAN JOURNAL OF NEUROLOGY. (pp. 598 - 598). WILEY-BLACKWELL

Schmierer, K; Parkes, HG; So, PW; An, SF; Brandner, S; Ordidge, RJ; Yousry, TA; (2010) High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis. BRAIN , 133 858 - 867. 10.1093/brain/awp335.

Schmierer, K; Thavarajah, JR; An, SF; Brandner, S; Miller, DH; Tozer, DJ; (2010) Effects of Formalin Fixation on Magnetic Resonance Indices in Multiple Sclerosis Cortical Gray Matter. J MAGN RESON IMAGING , 32 (5) 1054 - 1060. 10.1002/jmri.22381.

Schmitz-Hubsch, T; Coudert, M; Giunti, P; Globas, C; Baliko, L; Fancellu, R; Mariotti, C; (2010) Self-Rated Health Status in Spinocerebellar Ataxia-Results from a European Multicenter Study. MOVEMENT DISORD , 25 (5) 587 - 595. 10.1002/mds.22740.

Schmitz-Hubsch, T; Fimmers, R; Rakowicz, M; Rola, R; Zdzienicka, E; Fancellu, R; Mariotti, C; (2010) Responsiveness of different rating instruments in spinocerebellar ataxia patients. NEUROLOGY , 74 (8) 678 - 684.

Schneider, SA; Paisan-Ruiz, C; Quinn, NP; Lees, AJ; Houlden, H; Hardy, J; Bhatia, KP; (2010) ATP13A2 Mutations (PARK9) Cause Neurodegeneration with Brain Iron Accumulation. MOVEMENT DISORD , 25 (8) 979 - 984. 10.1002/mds.22947.

Scholz, S.W.; (2010) The promise of genome‐wide SNP genotyping: from population genetics to disease gene identification. Doctoral thesis, UCL (University College London). Green open access


Schorge, S; van de Leemput, J; Singleton, A; Houlden, H; Hardy, J; (2010) Human ataxias: a genetic dissection of inositol triphosphate receptor (ITPR1)-dependent signaling. TRENDS NEUROSCI , 33 (5) 211 - 219. 10.1016/j.tins.2010.02.005.

Schott, JM; Reiniger, L; Thom, M; Holton, JL; Grieve, J; Brandner, S; Warren, JD; (2010) Brain biopsy in dementia: clinical indications and diagnostic approach. ACTA NEUROPATHOL , 120 (3) 327 - 341. 10.1007/s00401-010-0721-y.

Schrag, A; Sheikh, S; Quinn, NP; Lees, AJ; Selai, C; Mathias, C; Litvan, I; (2010) A Comparison of Depression, Anxiety, and Health Status in Patients with Progressive Supranuclear Palsy and Multiple System Atrophy. MOVEMENT DISORD , 25 (8) 1077 - 1081. 10.1002/mds.22794.

Schrag, A; Sheikh, S; Quinn, NP; Lees, AJ; Selai, C; Mathias, C; Litvan, I; (2010) A comparison of depression, anxiety, and health status in patients with progressive supranuclear palsy and multiple system atrophy. Movement Disorders , 25 (8) pp. 1077-1081. 10.1002/mds.22794.

Schwingenschuh, P; Ruge, D; Edwards, MJ; Terranova, C; Katschnig, P; Carrillo, F; Silveira-Moriyama, L; (2010) Distinguishing SWEDDs Patients with Asymmetric Resting Tremor from Parkinson's Disease: A Clinical and Electrophysiological Study. MOVEMENT DISORD , 25 (5) 560 - 569. 10.1002/mds.23019. Gold open access

Sebastian, CL; Roiser, JP; Tan, GCY; Viding, E; Wood, NW; Blakemore, SJ; (2010) Effects of age and MAOA genotype on the neural processing of social rejection. GENES BRAIN BEHAV , 9 (6) 628 - 637. 10.1111/j.1601-183X.2010.00596.x.

Selikhova, M; O'Sullivan, SS; Guekht, A; Revesz, T; Lees, A; (2010) Clinico- Demographical Correlations of Dementia in Pathologically Confirmed PD. MOVEMENT DISORD , 25 S693 - S693.

Selnes, P; Blennow, K; Zetterberg, H; Grambaite, R; Rosengren, L; Johnsen, L; Stenset, V; (2010) Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid. Cerebrospinal Fluid Res , 7 10-. 10.1186/1743-8454-7-10.

Sequeiros, J; Martindale, J; Seneca, S; Giunti, P; Kämäräinen, O; Volpini, V; Weirich, H; (2010) EMQN Best Practice Guidelines for molecular genetic testing of SCAs. Eur J Hum Genet , 18 (11) pp. 1173-1176. 10.1038/ejhg.2010.8.

Setó-Salvia, N; Clarimón, J; (2010) Genetics of Alzheimer's disease. Revista de Neurologia , 50 (6) pp. 360-364.

Setó-Salvia, N; Clarimón, J; (2010) [Genetics of Alzheimer's disease]. Rev Neurol , 50 (6) pp. 360-364.

Sewry, CA; Holton, JH; Dick, DJ; Jacques, TS; Muntoni, F; Hanna, MG; (2010) Zebra body myopathy resolved. Presented at: UNSPECIFIED.

Sharma, S.; (2010) LRRK2 genetics and expression in the Parkinsonian brain. Doctoral thesis, UCL (University College London). Green open access

Shatunov, A; Mok, K; Newhouse, S; Weale, ME; Smith, B; Vance, C; Johnson, L; (2010) Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study. LANCET NEUROL , 9 (10) 986 - 994. 10.1016/S1474-4422(10)70197-6.

Sibley, CR; Seow, Y; Wood, MJA; (2010) Novel RNA-based Strategies for Therapeutic Gene Silencing. MOLECULAR THERAPY , 18 (3) pp. 466-476. 10.1038/mt.2009.306.

Silveira-Moriyama, L; Azevedo, AMS; Ranvaud, R; Barbosa, ER; Doty, RL; Lees, AJ; (2010) Applying a new version of the Brazilian-Portuguese UPSIT smell test in Brazil. Arquivos de Neuro-Psiquiatria , 68 (5) pp. 700-705. Gold open access

Silveira-Moriyama, L; Azevedo, AMS; Ranvaud, R; Barbosa, ER; Doty, RL; Lees, AJ; (2010) Applying a new version of the Brazilian-Portuguese UPSIT smell test in Brazil. ARQ NEURO-PSIQUIAT , 68 (5) 700 - 705. 10.1590/S0004-282X2010000500005. Green open access

Silveira-Moriyama, L; Gontu, V; Birchall, J; Patterson, J; Grosset, DG; Bain, P; Bajaj, NPS; (2010) Clinical presentation of SWEDDS with abnormal olfaction. In: MOVEMENT DISORDERS. (pp. S536 - S536). WILEY-LISS

Silveira-Moriyama, L; Hughes, G; Church, A; Ayling, H; Williams, DR; Petrie, A; Holton, J; (2010) Hyposmia in Progressive Supranuclear Palsy. MOVEMENT DISORD , 25 (5) 570 - 577. 10.1002/mds.22688.

Silveira-Moriyama, L; Munhoz, RP; Carvalho, MJ; Raskin, S; Rogaeva, E; Moriyama, T; Aguiar, PC; (2010) Olfactory Loss in LRRK2 Related Parkinsonism. In: NEUROLOGY. (pp. A254 - A255). LIPPINCOTT WILLIAMS & WILKINS

Silveira-Moriyama, L; Munhoz, RP; De J Carvalho, M; Raskin, S; Rogaeva, E; De C Aguiar, P; Bressan, RA; (2010) Olfactory heterogeneity in LRRK2 related Parkinsonism. Movement Disorders , 25 (16) pp. 2879-2883. 10.1002/mds.23325.

Sinclair, CDJ; Miranda, MA; Cowley, P; Morrow, JM; Davagnanam, I; Mehta, H; Hanna, MG; (2010) Magnetic resonance imaging and sciatic nerve cross-sectional area in inherited and inflammatory neuropathies. In: NEUROMUSCULAR DISORDERS. (pp. S29 - S29). PERGAMON-ELSEVIER SCIENCE LTD

Sinclair, CDJ; Morrow, JM; Yousry, TA; Reilly, MM; Hanna, MG; Golay, X; Thornton, JS; (2010) Inter-scan reproducibility of quantitative neuromuscular MRI. In: NEUROMUSCULAR DISORDERS. (pp. S28 - S28). PERGAMON-ELSEVIER SCIENCE LTD

Sinclair, CDJ; Samson, RS; Thomas, DL; Weiskopf, N; Lutti, A; Thornton, JS; Golay, X; (2010) Quantitative Magnetization Transfer in In Vivo Healthy Human Skeletal Muscle at 3 T. MAGN RESON MED , 64 (6) 1739 - 1748. 10.1002/mrm.22562.

Sinclair, CDJ; Samson, RS; Thomas, DL; Weiskopf, N; Lutti, A; Thornton, JS; Golay, X; (2010) Quantitative magnetization transfer MRI: a potential new source of biomarkers in skeletal muscle? In: NEUROMUSCULAR DISORDERS. (pp. S28 - S29). PERGAMON-ELSEVIER SCIENCE LTD

Singleton, AB; Hardy, J; Traynor, BJ; Houlden, H; (2010) Towards a complete resolution of the genetic architecture of disease. TRENDS GENET , 26 (10) 438 - 442. 10.1016/j.tig.2010.07.004.

Sjölander, A; Zetterberg, H; Andreasson, U; Minthon, L; Blennow, K; (2010) BACE1 gene variants do not influence BACE1 activity, levels of APP or Aβ isoforms in CSF in Alzheimer's disease. Mol Neurodegener , 5 37-. 10.1186/1750-1326-5-37.

Sofola, O; Kerr, F; Rogers, I; Killick, R; Augustin, H; Gandy, C; Allen, MJ; (2010) Inhibition of GSK-3 ameliorates Aβ pathology in an adult-onset drosophila model of Alzheimer's Disease. PLoS Genetics , 6 (9) , Article e1001087. 10.1371/journal.pgen.1001087. Green open access

Sokolovsky, N; Cook, A; Hunt, H; Giunti, P; Cipolotti, L; (2010) Erratum: A preliminary characterisation of cognition and social cognition in spinocerebellar ataxia types 2, 1, and 7 (Behavioural Neurology (2010) 23:1 (17-29) DOI: 10.3233/BEN20100270). Behavioural Neurology , 23 (3) 159-. 10.3233/BEN-2010-0280.

Sokolovsky, N; Cook, A; Hunt, H; Giunti, P; Cipolotti, L; (2010) A preliminary characterisation of cognition and social cognition in spinocerebellar ataxia types 2, 1, and 7. BEHAV NEUROL , 23 (1-2) 17 - 29. 10.3233/BEN-2010-0270.

Soneson, C; Fontes, M; Zhou, Y; Denisov, V; Paulsen, JS; Kirik, D; Petersén, A; (2010) Early changes in the hypothalamic region in prodromal Huntington disease revealed by MRI analysis. Neurobiol Dis , 40 (3) pp. 531-543. 10.1016/j.nbd.2010.07.013.

Soreq, L; (2010) Serum Cholinesterase Activities Distinguish between Stroke Patients and Controls and Predict 12-Month Mortality. Molecular Medicine , 16 (7-8) 10.2119/molmed.2010.00015.

Soutar, MP; Kim, WY; Williamson, R; Peggie, M; Hastie, CJ; McLauchlan, H; Snider, WD; (2010) Evidence that glycogen synthase kinase-3 isoforms have distinct substrate preference in the brain. J Neurochem , 115 (4) pp. 974-983. 10.1111/j.1471-4159.2010.06988.x.

Spitzer, P; Klafki, HW; Blennow, K; Buée, L; Esselmann, H; Herruka, SK; Jimenez, C; (2010) cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases. Int J Alzheimers Dis , 2010 10.4061/2010/548145.

Stahmann, N; Woods, A; Spengler, K; Heslegrave, A; Bauer, R; Krause, S; Viollet, B; (2010) Activation of AMP-activated Protein Kinase by Vascular Endothelial Growth Factor Mediates Endothelial Angiogenesis Independently of Nitric-oxide Synthase. Journal of Biological Chemistry , 285 (14) pp. 10638-10652. 10.1074/jbc.M110.108688.

Stamelou, M; de Silva, R; Arias-Carrion, O; Boura, E; Hollerhage, M; Oertel, WH; Muller, U; (2010) Rational therapeutic approaches to progressive supranuclear palsy. BRAIN , 133 1578 - 1590. 10.1093/brain/awq115.

Stomrud, E; Hansson, O; Zetterberg, H; Blennow, K; Minthon, L; Londos, E; (2010) Correlation of longitudinal cerebrospinal fluid biomarkers with cognitive decline in healthy older adults. Arch Neurol , 67 (2) pp. 217-223. 10.1001/archneurol.2009.316.

Suh, J; Im, DS; Moon, GJ; Ryu, KS; de Silva, R; Choi, IS; Lees, AJ; (2010) Hypoxic ischemia and proteasome dysfunction alter tau isoform ratio by inhibiting exon 10 splicing. J NEUROCHEM , 114 (1) 160 - 170. 10.1111/j.1471-4159.2010.06732.x.

Sämgård, K; Zetterberg, H; Blennow, K; Hansson, O; Minthon, L; Londos, E; (2010) Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity. Int J Geriatr Psychiatry , 25 (4) pp. 403-410. 10.1002/gps.2353.


TT, DKPJBLLDWCSJRCAECNQSP-HIOTHSGIW; (2010) "Frontal" behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness. J Neuropsychiatry Clin Neurosci , 22 pp. 196-207.

Tan, GCY; Doke, TF; Ashburner, J; Wood, NW; Frackowiak, RSJ; (2010) Normal variation in fronto-occipital circuitry and cerebellar structure with an autism-associated polymorphism of CNTNAP2. NEUROIMAGE , 53 (3) 1030 - 1042. 10.1016/j.neuroimage.2010.02.018.

Thorsell, A; Bjerke, M; Gobom, J; Brunhage, E; Vanmechelen, E; Andreasen, N; Hansson, O; (2010) Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease. Brain Res , 1362 pp. 13-22. 10.1016/j.brainres.2010.09.073.

Thorvaldsson, V; Nordlund, A; Reinvang, I; Blennow, K; Zetterberg, H; Wallin, A; Johansson, B; (2010) Memory in individuals with mild cognitive impairment in relation to APOE and CSF Abeta42. Int Psychogeriatr , 22 (4) pp. 598-606. 10.1017/S1041610210000335.

Tomidokoro, Y; Tamaoka, A; Holton, JL; Lashley, T; Frangione, B; Revesz, T; Rostagno, A; (2010) Pyroglutamate formation at the N-termini of ABri molecules in familial british dementia is not restricted to the central nervous system. Hirosaki Medical Journal , 61 (SUPPL.)

Tomlinson, SE; Burke, D; Hanna, M; Koltzenburg, M; Bostock, H; (2010) IN VIVO ASSESSMENT OF HCN CHANNEL CURRENT (I-h) IN HUMAN MOTOR AXONS. MUSCLE NERVE , 41 (2) 247 - 256. 10.1002/mus.21482.

Tomlinson, SE; Tan, SV; Kullmann, DM; Griggs, RC; Burke, D; Hanna, MG; Bostock, H; (2010) Nerve excitability studies characterize K(V)1.1 fast potassium channel dysfunction in patients with episodic ataxia type 1. BRAIN , 133 3530 - 3540. 10.1093/brain/awq318.

Tucci, A; Nalls, MA; Houlden, H; Revesz, T; Singleton, AB; Wood, NW; Hardy, J; (2010) Genetic variability at the PARK16 locus. EUR J HUM GENET , 18 (12) 1356 - 1359. 10.1038/ejhg.2010.125.


Ule, J; Wang, Z; Kayikci, M; Briese, M; Zarnack, K; Luscombe, NM; Rot, G; (2010) iCLIP predicts the dual splicing effects of TIA-RNA interactions. PLoS Biology , 8 (10) 10.1371/journal.pbio.1000530. Gold open access

Urwin, H; Josephs, KA; Rohrer, JD; Mackenzie, IR; Neumann, M; Authier, A; Seelaar, H; (2010) FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. ACTA NEUROPATHOL , 120 (1) 33 - 41. 10.1007/s00401-010-0698-6.


Vaarmann, A; Gandhi, S; Abramov, AY; (2010) Dopamine Induces Ca2+ Signaling in Astrocytes through Reactive Oxygen Species Generated by Monoamine Oxidase. J BIOL CHEM , 285 (32) 25018 - 25023. 10.1074/jbc.M110.111450. Gold open access

Vaarmann, A; Gandhi, S; Gourine, AV; Abramov, AY; (2010) Novel pathway for an old neurotransmitter: Dopamine-induced neuronal calcium signalling via receptor-independent mechanisms. CELL CALCIUM , 48 (2-3) 176 - 182. 10.1016/j.ceca.2010.08.008.

Van Deerlin, VM; Sleiman, PMA; Martinez-Lage, M; Chen-Plotkin, A; Wang, LS; Graff-Radford, NR; Dickson, DW; (2010) Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP43 inclusions. NAT GENET , 42 (3) 234 - U34. 10.1038/ng.536.

Vandrovcova, J; Anaya, F; Kay, V; Lees, A; Hardy, J; de Silva, R; (2010) Disentangling the Role of the Tau Gene Locus in Sporadic Tauopathies. CURR ALZHEIMER RES , 7 (8) 726 - 734.

van de Leemput, J; Wavrant-De Vrieze, F; Rafferty, I; Bras, JM; Giunti, P; Fisher, EMC; Hardy, JA; (2010) Sequencing Analysis of the ITPR1 Gene in a Pure Autosomal Dominant Spinocerebellar Ataxia Series. MOVEMENT DISORD , 25 (6) 771 - 773. 10.1002/mds.22970.

van de Leemput, J; Wavrant-De Vrièze, F; Rafferty, I; Bras, JM; Giunti, P; Fisher, EMC; Hardy, JA; (2010) Sequencing analysis of the ITPR1 gene in a pure autosomal dominant spinocerebellar ataxia series. Movement disorders : official journal of the Movement Disorder Society , 25 (6) pp. 763-765.

von Otter, M; Landgren, S; Nilsson, S; Celojevic, D; Bergström, P; Håkansson, A; Nissbrandt, H; (2010) Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease. BMC Med Genet , 11 36-. 10.1186/1471-2350-11-36.

von Otter, M; Landgren, S; Nilsson, S; Lundvall, C; Minthon, L; Bogdanovic, N; Andreasen, N; (2010) Kinesin light chain 1 gene haplotypes in three conformational diseases. Neuromolecular Med , 12 (3) pp. 229-236. 10.1007/s12017-009-8103-0.

von Otter, M; Landgren, S; Nilsson, S; Zetterberg, M; Celojevic, D; Bergström, P; Minthon, L; (2010) Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract. Mech Ageing Dev , 131 (2) pp. 105-110. 10.1016/j.mad.2009.12.007.


Wain, LV; Shrine, NRG; Shaw, C; Powell, JF; Hardy, J; Shaw, P; Morrison, KE; (2010) The Role of Common Copy Number Variation in Amyotrophic Lateral Sclerosis (ALS). In: GENETIC EPIDEMIOLOGY. (pp. 929 - 930). WILEY-BLACKWELL

Wallin, AK; Blennow, K; Zetterberg, H; Londos, E; Minthon, L; Hansson, O; (2010) CSF biomarkers predict a more malignant outcome in Alzheimer disease. Neurology , 74 (19) pp. 1531-1537. 10.1212/WNL.0b013e3181dd4dd8.

Wang, CL; Szpiech, ZA; Degnan, JH; Jakobsson, M; Pemberton, TJ; Hardy, JA; Singleton, AB; (2010) Comparing Spatial Maps of Human Population-Genetic Variation Using Procrustes Analysis. STAT APPL GENET MOL , 9 (1) , Article 13. 10.2202/1544-6115.1493.

Wang, Z; Kayikci, M; Briese, M; Zarnack, K; Luscombe, NM; Rot, G; Zupan, B; (2010) iCLIP predicts the dual splicing effects of TIA-RNA interactions. PLoS Biol , 8 (10) , Article e1000530. 10.1371/journal.pbio.1000530.

Ward, SJ; Karakoula, K; Phipps, KP; Harkness, W; Hayward, R; Thompson, D; Jacques, TS; (2010) Cytogenetic analysis of paediatric astrocytoma using comparative genomic hybridisation and fluorescence in-situ hybridisation. J NEURO-ONCOL , 98 (3) 305 - 318. 10.1007/s11060-009-0081-4.

Warner, TT; Granata, A; Schiavo, G; (2010) TorsinA and DYT1 dystonia: a synaptopathy? Biochem Soc Trans , 38 (2) pp. 452-456. 10.1042/BST0380452.


Wedderburn, LR; Varsani, H; Charman, SC; Amato, AA; Banwell, B; Bove, KE; Corse, AM; (2010) Validation of a histopathological score tool for the measurement of severity in muscle biopsies from patients with juvenile dermatomyositis. Presented at: UNSPECIFIED.

Weil, RS; Furl, N; Ruff, CC; Symmonds, M; Flandin, G; Dolan, RJ; Driver, J; (2010) Rewarding Feedback After Correct Visual Discriminations Has Both General and Specific Influences on Visual Cortex. J NEUROPHYSIOL , 104 (3) 1746 - 1757. 10.1152/jn.00870.2009.

Weil, RS; Rees, G; (2010) Decoding the neural correlates of consciousness. CURR OPIN NEUROL , 23 (6) 649 - 655. 10.1097/WCO.0b013e32834028c7.

Wesnes, K; Edgar, C; Andreasen, N; Annas, P; Basun, H; Lannfelt, L; Zetterberg, H; (2010) Computerized cognition assessment during acetylcholinesterase inhibitor treatment in Alzheimer's disease. Acta Neurol Scand , 122 (4) pp. 270-277. 10.1111/j.1600-0404.2009.01309.x.

Wiig, EH; Annas, P; Basun, H; Andreasen, N; Lannfelt, L; Zetterberg, H; Blennow, K; (2010) The stability of AQT processing speed, ADAS-Cog and MMSE during acetylcholinesterase inhibitor treatment in Alzheimer's disease. Acta Neurol Scand , 121 (3) pp. 186-193. 10.1111/j.1600-0404.2009.01160.x.

Williams, DR; Lees, AJ; (2010) What Features Improve the Accuracy of the Clinical Diagnosis of Progressive Supranuclear Palsy-parkinsonism (PSP-P)? MOVEMENT DISORD , 25 (3) 357 - 362. 10.1002/mds.22977.

Willis, TA; Hollingsworth, KG; Sveen, ML; Morrow, J; Vandenheede, J; Mayhew, A; Eagle, M; (2010) Assessing muscle pathology by MRI in LGMD2I. In: NEUROMUSCULAR DISORDERS. (pp. 666 - 666). PERGAMON-ELSEVIER SCIENCE LTD

Wray, S; Hardy, J; (2010) All MAPT out?: Well-travelled pathways into neurodegeneration. Biochemist , 32 (2) pp. 14-17.

Wray, S; Lewis, PA; (2010) A tangled web - tau and sporadic Parkinson's disease. Front Psychiatry , 1 150-. 10.3389/fpsyt.2010.00150.

Wu, K; O'Sullian, S; Politis, M; Bose, S; Lees, A; Piccini, P; (2010) REWARDING VISUAL CUES INCREASE DOPAMINE NEUROTRANSMISSION IN PARKINSON'S PATIENTS WITH IMPULSE CONTROL DISORDERS: A PET STUDY. In: (Proceedings) Annual Meeting of the Association-of-British-Neurologists. (pp. E29-E30). B M J PUBLISHING GROUP

Wu, K; Politis, M; O'Sullivan, S; Bose, S; Lees, A; Piccini, P; (2010) Impulse Control Disorders Subtypes in Parkinson's Disease: Clinical and PET Correlations. MOVEMENT DISORDERS , 25 S725-S726.

Wu, K; Politis, M; Warsi, S; Loane, C; O'Sullivan, S; Lees, A; Piccini, P; (2010) Measuring Severity of Impulse Control Disorders in Parkinson's Disease Using Objective Validated Questionnaire. MOVEMENT DISORDERS , 25 S683-S684.


Yao, Z; Gandhi, S; Plun-Favreau, H; Wood, NW; Abramov, AY; (2010) PINK1 Deficiency and Mitochondrial Dysfunction in Neurons and Skeletal Myocytes. BIOPHYSICAL JOURNAL , 98 (3) 381A-381A.

Yip, HLK; Lees, AJ; Revesz, T; Silveira-Moriyama, L; (2010) The pathological substrate for clinically diagnosed Parkinson's disease. In: MOVEMENT DISORDERS. (pp. S368 - S368). WILEY-LISS

Yousry, TA; Lees, AJ; (2010) Imaging of Movement Disorders Preface. NEUROIMAG CLIN N AM , 20 (1) XIII - XIII. 10.1016/j.nic.2009.10.004.


Zetterberg, H; Blennow, K; Hanse, E; (2010) Amyloid beta and APP as biomarkers for Alzheimer's disease. Exp Gerontol , 45 (1) pp. 23-29. 10.1016/j.exger.2009.08.002.

Zetterberg, H; Mattsson, N; Blennow, K; (2010) Cerebrospinal fluid analysis should be considered in patients with cognitive problems. Int J Alzheimers Dis , 2010 163065-. 10.4061/2010/163065.

Zetterberg, H; Mattsson, N; Blennow, K; Olsson, B; (2010) Use of theragnostic markers to select drugs for phase II/III trials for Alzheimer disease. Alzheimers Res Ther , 2 (6) 32-. 10.1186/alzrt56.

Zetterberg, H; Mattsson, N; Shaw, LM; Blennow, K; (2010) Biochemical markers in Alzheimer's disease clinical trials. Biomark Med , 4 (1) pp. 91-98.

Zetterberg, H; Tullhög, K; Hansson, O; Minthon, L; Londos, E; Blennow, K; (2010) Low incidence of post-lumbar puncture headache in 1,089 consecutive memory clinic patients. Eur Neurol , 63 (6) pp. 326-330. 10.1159/000311703.

Zetterberg, HL; (2010) A vocabulary justifying revolutions. Sociologisk Forskning , 47 (3) pp. 75-81.

Zetterberg, M; Sjölander, A; von Otter, M; Palmér, MS; Landgren, S; Minthon, L; Wallin, A; (2010) Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) S18Y polymorphism in Alzheimer's disease. Mol Neurodegener , 5 11-. 10.1186/1750-1326-5-11.

Zetzsche, T; Rujescu, D; Hardy, J; Hampel, H; (2010) Advances and perspectives from genetic research: development of biological markers in Alzheimer's disease. EXPERT REV MOL DIAGN , 10 (5) 667 - 690. 10.1586/ERM.10.48.

Zhang, H; Sun, S; Herreman, A; De Strooper, B; Bezprozvanny, I; (2010) Role of presenilins in neuronal calcium homeostasis. J Neurosci , 30 (25) pp. 8566-8580. 10.1523/JNEUROSCI.1554-10.2010.

Zhou, HY; Lillis, S; Loy, RE; Ghassemi, F; Rose, MR; Norwood, F; Mills, K; (2010) Multi-minicore disease and atypical periodic paralysis associated with novel mutations in the skeletal muscle ryanodine receptor (RYR1) gene. NEUROMUSCULAR DISORD , 20 (3) 166 - 173. 10.1016/j.nmd.2009.12.005. Gold open access

Zimon, M; Baets, J; Auer-Grumbach, M; Berciano, J; Garcia, A; Lopez-Laso, E; Merlini, L; (2010) Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies. BRAIN , 133 1798 - 1809. 10.1093/brain/awq109.

Zuberi, SM; Eunson, LH; Spauschus, A; De Silva, R; Tolmie, J; Wood, NW; McWilliam, RC; (2010) A novel mutation in the human voltage-gated potassium channel gene (Kv1.1) associates with episodic ataxia type 1 and sometimes with partial epilepsy (vol 122, pg 817, 1999). BRAIN , 133 1569 - 1569. 10.1093/brain/awn181.

This list was generated on Sun Oct 23 04:15:08 2016 BST.